
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Osteoporosis - Musculoskeletal and Connective Tissue Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "d664f6b2-f617-4e76-82f0-06eb947c1f80";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v906744";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "c398ef99-e4cb-4572-b587-f54f2629c521",
 VasontId : "v906727"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "47e70a29-213f-41bf-be95-acdbe09995db",
 VasontId : "v878831"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="d664f6b2-f617-4e76-82f0-06eb947c1f80">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '57a38f2b-7e90-45fd-b08b-f8197cd7ab9f';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Osteoporosis
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/bolster-marcy.html">Marcy B. Bolster</a></strong>
 <p class="topic__authors--description">, MD, Harvard Medical School</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Sep 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="733.0;MM958" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v906751" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v906762" class="topicmenu_mobile__paragraph">Classification</a>
 </li>
 <li>
 <a href="#v906825" class="topicmenu_mobile__paragraph">Risk Factors</a>
 </li>
 <li>
 <a href="#v906828" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v906836" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v906887" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v906953" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v23349555" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v23349573" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="DXA Scan">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="474" loading="lazy">
 </div>
 <span class="hero__description">
 DXA Scan
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"DXA Scan","Credits":"\u003cspan id=\u0022v85655412\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Marcy B. Bolster, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"2e0df931-6a4c-4c63-a78d-cdb2bd2ae071","Title":"DXA%20Scan","ShareUrlTitle":"dxa-scan","Description":"%3Cp%3EThis%20image%20is%20an%20example%20of%20a%20DXA%20scan%20report.%20In%20the%20graph%2C%20the%20area%20in%20light%20blue%20represents%20osteopenia%20and%20the%20area%20in%20dark%20blue%20represents%20osteoporosis.%20The%20patient%E2%80%99s%20values%20are%20represented%20by%20the%20%E2%80%9C%2B%E2%80%9D%20sign%20inside%20the%20circle%20in%20each%20graph.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34402304","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"474","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"DXA%20Scan","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Osteoporotic Compression Fracture">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/b/o/l/bolster-l1-vert-compression-osteoporosis-pv-red-arrow.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="835" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Osteoporotic Compression...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Osteoporotic Compression Fracture","Credits":"\u003cspan id=\u0022v85660083\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003ePhoto courtesy of Marcy B. Bolster, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"6c0cd8bb-fde8-4bf4-b0ad-3237d39b72f0","Title":"Osteoporotic%20Compression%20Fracture","ShareUrlTitle":"osteoporotic-compression-fracture","Description":"%3Cp%3EThis%20x-ray%20shows%20a%20severe%20osteoporotic%20compression%20fracture%20of%20the%20first%20lumbar%20vertebra%20%28L1%3B%20arrow%29.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/b/o/l/bolster-l1-vert-compression-osteoporosis-pv-red-arrow.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/o/l/bolster-l1-vert-compression-osteoporosis-pv-red-arrow.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v25232688","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"835","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Osteoporotic%20Compression%20Fracture","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Causes of Secondary Osteoporosis">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Causes of Secondary Osteoporosis
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"c06e6d61-f310-402b-b4cc-1effc8f3663d","Title":"Causes%20of%20Secondary%20Osteoporosis","ShareUrlTitle":"causes-of-secondary-osteoporosis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v906785","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Causes%20of%20Secondary%20Osteoporosis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--sidebar" data-group-name="sidebar" title="Differentiating Osteoporosis and Osteomalacia">
 <div class="hero__sidebar">
 <img class="hero__sidebar--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Differentiating Osteoporosis...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"62a867c1-f2e8-4b71-acc0-529ca9d064cb","Title":"Differentiating%20Osteoporosis%20and%20Osteomalacia","ShareUrlTitle":"differentiating-osteoporosis-and-osteomalacia","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Sidebar","UniqueId":"v7821335","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Differentiating%20Osteoporosis%20and%20Osteomalacia","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Sidebar","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v906749" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures with minor or inapparent trauma, particularly in the thoracic and lumbar spine, wrist, and hip (called fragility fractures). Diagnosis is by dual-energy x-ray absorptiometry (DXA scan) or by confirmation of a fragility fracture. Prevention and treatment involve risk factor modification; calcium and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> supplements; exercises to maximize bone and muscle strength, improve balance, and minimize the risk of falls; and pharmacotherapy to preserve bone mass or stimulate new bone formation.</div></p></div> <section id="v906751" class="topic__section FHead"> <h2 id="Pathophysiology_v906752" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v906752" class="anchor"></span> Pathophysiology of Osteoporosis </h2> <div class="topic__content"> <span id="v906753" class="anchor"></span><div class="para"> <p>Bone is continually being formed and resorbed. Normally, bone formation and resorption are closely balanced. Osteoblasts (cells that make the organic matrix of bone and then mineralize bone) and osteoclasts (cells that resorb bone) are regulated by <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>parathyroid hormone</span> (PTH), <span class="genericDrug" data-showrollover="false">calcitonin</span>, <span class="genericDrug" data-showrollover="false">estrogen</span>, <span class="genericDrug" data-showrollover="false">vitamin D</span>, various cytokines, and other local factors such as prostaglandins. </p></div><span id="v906758" class="anchor"></span><div class="para"> <p>Peak bone mass in men and women occurs around age 30. Men have higher bone mass than women. (Previous data suggesting people with African ancestry achieve higher peak bone mass are currently being questioned.) After achieving its peak, bone mass plateaus for about 10 years, during which time bone formation approximately equals bone resorption. Beginning with menopause, bone loss accelerates in women to approximately 2% a year for about 10 years and then the rate of loss decelerates (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v84056364" data-toggle="tooltip" title="Pathophysiology reference" data-id="e2ac6c4f-d4cd-4f1f-a501-a20150906966" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">1</a><span id="e2ac6c4f-d4cd-4f1f-a501-a20150906966" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v84056364"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology reference </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology reference" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v906761" class="anchor"></span><div class="para"> <p>Osteoporotic bone loss affects cortical and trabecular (cancellous) bone. Cortical thickness and the number and size of trabeculae decrease, resulting in increased porosity. Trabeculae may be disrupted or entirely absent. Trabecular bone loss occurs more rapidly than cortical bone loss because trabecular bone is more porous and bone turnover is higher. However, loss of both types contributes to skeletal fragility.</p></div> <section id="v7821313" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v906752_v7821314" class="topic__header--subsection"> <span id="v7821314" class="anchor"></span> Fragility fractures </h3> <div class="topic__content"> <span id="v7821317" class="anchor"></span><div class="para"> <p>A fragility fracture is one that occurs after less trauma than might be expected to fracture a normal bone. Fractures resulting from falls from a standing height or less, including falls out of bed, are typically considered fragility fractures. The most common sites for fragility fractures are the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v23349472" class="anchor"></span><div class="para"> <p>Spine (<a href="./{66BE1953-E840-4955-B1C6-A6B7BF4D7A2E}.html" data-toggle="tooltip" title="Vertebral Compression Fractures" data-id="47cf77a4-a8f5-46e6-9815-d56c80a93345" data-itemid="66be1953-e840-4955-b1c6-a6b7bf4d7a2e">thoracic and lumbar vertebral compression fractures</a><span id="47cf77a4-a8f5-46e6-9815-d56c80a93345" class="d-none xref"> <span class="tooltip-container"> <a href="./{66BE1953-E840-4955-B1C6-A6B7BF4D7A2E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vertebral Compression Fractures </span> Most vertebral compression fractures are a consequence of osteoporosis, are asymptomatic or minimally symptomatic, and occur with no or minimal trauma. (See also Overview of Fractures.) Vertebral... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0252504-anteroposterior-and-lateral-view-compression-fracture-x-ray-science-photo-library-high-arrows.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Vertebral Compression Fractures" loading="lazy"> </span> </a> </span> </span>—the most common osteoporosis-related fracture)</p></div></li><li class="topic__listitem"><span id="v23349474" class="anchor"></span><div class="para"> <p> <a href="./{94006756-ABE6-4738-97EA-4C2885DF8490}.html" data-toggle="tooltip" title="Hip Fractures" data-id="f76f186e-604e-44f9-9d49-455b3b9cb332" data-itemid="94006756-abe6-4738-97ea-4c2885df8490">Femoral neck</a><span id="f76f186e-604e-44f9-9d49-455b3b9cb332" class="d-none xref"> <span class="tooltip-container"> <a href="./{94006756-ABE6-4738-97EA-4C2885DF8490}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hip Fractures </span> Hip fractures may occur in the head, neck, or area between or below the trochanters (prominences) of the femur. These fractures are most common among older patients, particularly those with... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0297583-femoral-neck-fracture-x-ray-science-photo-library-arrows-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hip Fractures" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v23349476" class="anchor"></span><div class="para"> <p> <a href="./{94006756-ABE6-4738-97EA-4C2885DF8490}.html" data-toggle="tooltip" title="Hip Fractures" data-id="e60a46f6-1883-477f-9ed5-281c0de3c075" data-itemid="94006756-abe6-4738-97ea-4c2885df8490">Greater trochanter</a><span id="e60a46f6-1883-477f-9ed5-281c0de3c075" class="d-none xref"> <span class="tooltip-container"> <a href="./{94006756-ABE6-4738-97EA-4C2885DF8490}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hip Fractures </span> Hip fractures may occur in the head, neck, or area between or below the trochanters (prominences) of the femur. These fractures are most common among older patients, particularly those with... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0297583-femoral-neck-fracture-x-ray-science-photo-library-arrows-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hip Fractures" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v84056361" class="anchor"></span><div class="para"> <p> <a href="./{A0445098-40E3-436F-81A2-576F4BFFFA54}.html" data-toggle="tooltip" title="Distal Radius Fractures" data-id="9961c094-f5c2-4903-8e8d-3626cd93292d" data-itemid="a0445098-40e3-436f-81a2-576f4bfffa54">Distal radius</a><span id="9961c094-f5c2-4903-8e8d-3626cd93292d" class="d-none xref"> <span class="tooltip-container"> <a href="./{A0445098-40E3-436F-81A2-576F4BFFFA54}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Distal Radius Fractures </span> Distal radius fractures usually result from a fall on an outstretched hand. (See also Overview of Fractures.) Most distal radius fractures are dorsally displaced or angulated (sometimes called... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/3/3/m3301081_subtle_distal_radius_fracture_x-ray_science_photo_library_high-arrow-correx.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Distal Radius Fractures" loading="lazy"> </span> </a> </span> </span></p></div></li></ul></div><span id="v23349477" class="anchor"></span><div class="para"> <p>Other sites may include the <a href="./{233CDF5D-F0C3-4426-A3B4-CAEB6E6212E3}.html" data-toggle="tooltip" title="Proximal Humeral Fractures" data-id="c171e364-e5cf-49bc-808f-4fb3fd82ea7b" data-itemid="233cdf5d-f0c3-4426-a3b4-caeb6e6212e3">proximal humerus</a><span id="c171e364-e5cf-49bc-808f-4fb3fd82ea7b" class="d-none xref"> <span class="tooltip-container"> <a href="./{233CDF5D-F0C3-4426-A3B4-CAEB6E6212E3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Proximal Humeral Fractures </span> Proximal humeral fractures are proximal to the surgical neck (see figure Key anatomic landmarks in the proximal humerus). Most are minimally displaced and angulated. Diagnosis is by plain x-ray... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/0/f0039171_proximal_humerus_fracture_x_ray_science_photo_library_high-arrow.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Proximal Humeral Fractures" loading="lazy"> </span> </a> </span> </span> and <a href="./{58CC8313-37E1-45F7-8C73-96C3E9F73745}.html" data-toggle="tooltip" title="Pelvic Fractures" data-id="a7104a33-e57a-41e6-985f-86be11476398" data-itemid="58cc8313-37e1-45f7-8c73-96c3e9f73745">pelvis</a><span id="a7104a33-e57a-41e6-985f-86be11476398" class="d-none xref"> <span class="tooltip-container"> <a href="./{58CC8313-37E1-45F7-8C73-96C3E9F73745}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pelvic Fractures </span> Pelvic fractures can involve the pubic symphysis, innominate bones, acetabulum, sacroiliac joint or sacrum. They range from minimally displaced stable injuries caused by low energy falls to... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0106063_pelvic_fracture_x-ray_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pelvic Fractures" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v39824480" class="anchor"></span><div class="para"> <p>Fractures at sites such as the nose, <a href="./{693161B2-274A-4AD8-99B0-0B58A3D42D95}.html" data-toggle="tooltip" title="Rib Fracture" data-id="c643dc28-5f50-433c-8114-ebf96d78a9ea" data-itemid="693161b2-274a-4ad8-99b0-0b58a3d42d95">ribs</a><span id="c643dc28-5f50-433c-8114-ebf96d78a9ea" class="d-none xref"> <span class="tooltip-container"> <a href="./{693161B2-274A-4AD8-99B0-0B58A3D42D95}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Rib Fracture </span> One or more ribs can be fractured due to blunt chest injury. (See also Overview of Thoracic Trauma.) This x-ray of the chest shows multiple fractures to the right ribs (seen on left). Typically... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0177566-rib-fractures-x-ray-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rib Fracture" loading="lazy"> </span> </a> </span> </span>, <a href="./{419151EE-7A73-4A75-88B4-1846C6BE4DF7}.html" data-toggle="tooltip" title="Clavicle Fractures" data-id="651773c7-c8fd-476d-83b9-00fd888f938f" data-itemid="419151ee-7a73-4a75-88b4-1846c6be4df7">clavicle</a><span id="651773c7-c8fd-476d-83b9-00fd888f938f" class="d-none xref"> <span class="tooltip-container"> <a href="./{419151EE-7A73-4A75-88B4-1846C6BE4DF7}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Clavicle Fractures </span> Clavicle fractures are among the most common fractures, particularly among children. Diagnosis is by plain x-ray. Most types are treated with a sling. (See also Overview of Fractures.) Clavicle... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0272620-clavicle-fracture-x-ray-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Clavicle Fractures" loading="lazy"> </span> </a> </span> </span>, patella, and <a href="./{11682D7E-2930-41F2-A840-105F6EE0B118}.html" data-toggle="tooltip" title="Stress Fractures" data-id="fb4f6c7d-9958-416b-bde7-943dc5c852ba" data-itemid="11682d7e-2930-41f2-a840-105f6ee0b118">metatarsals</a><span id="fb4f6c7d-9958-416b-bde7-943dc5c852ba" class="d-none xref"> <span class="tooltip-container"> <a href="./{11682D7E-2930-41F2-A840-105F6EE0B118}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Stress Fractures </span> Stress fractures are small incomplete fractures that often involve the metatarsal shafts. They are caused by repetitive weight-bearing stress. Stress fractures do not usually result from a discrete... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> are not considered osteoporosis-related fractures.</p></div> </div> </section> <section id="v84056363" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v906752_v84056364" class="topic__header--subsection"> <span id="v84056364" class="anchor"></span> Pathophysiology reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84056367" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266953/">Finkelstein JS, Brockwell SE, Mehta V, et al</a>: Bone mineral density changes during the menopause transition in a multiethnic cohort of women. <i>J Clin Endocrinol Metab</i> 93(3):861-868, 2008. doi:10.1210/jc.2007-1876</p></div></li></ul></div> </div> </section> </div> </section> <section id="v906762" class="topic__section FHead"> <h2 id="Classification_v906763" class="topic__header--section" data-originaltitle="Classification"> <span id="v906763" class="anchor"></span> Classification of Osteoporosis </h2> <div class="topic__content"> <span id="v906764" class="anchor"></span><div class="para"> <p>Osteoporosis can develop as a primary disorder of bone turnover or secondarily due to some other factor. The sites of fracture are similar in primary and secondary osteoporosis.</p></div> <section id="v906765" class="topic__section GHead"> <span></span> <h3 id="Classification_v906763_v906766" class="topic__header--subsection"> <span id="v906766" class="anchor"></span> Primary osteoporosis </h3> <div class="topic__content"> <span id="v906767" class="anchor"></span><div class="para"> <p>Nearly all occurrences of osteoporosis in men and women are primary, without an identifiable underlying cause. Most cases occur in postmenopausal women and older men. However, certain conditions may accelerate bone loss in patients with primary osteoporosis. Gonadal insufficiency is an important factor in both men and women; other factors include decreased calcium intake, <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html" data-toggle="tooltip" title="Vitamin D Deficiency and Dependency" data-id="5ac7e8a5-a968-4186-840f-13145b89903d" data-itemid="592490cc-f7ff-4124-ba17-4a6846cb573b">low <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> levels</a><span id="5ac7e8a5-a968-4186-840f-13145b89903d" class="d-none xref"> <span class="tooltip-container"> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vitamin D Deficiency and Dependency </span> Inadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone mineralization, causing rickets in children and osteomalacia in adults and possibly contributing... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, certain medications, and <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434523" data-toggle="tooltip" title="Primary hyperparathyroidism" data-id="649cb3ec-96bd-48c4-9a55-e9e42f0d5ff0" data-itemid="e9243843-2c44-45bf-b956-8f604f0e34cb">hyperparathyroidism</a><span id="649cb3ec-96bd-48c4-9a55-e9e42f0d5ff0" class="d-none xref"> <span class="tooltip-container"> <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434523"> <span class="tooltip-content"> <span class="tooltip-heading"> Primary hyperparathyroidism </span> Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Some patients have an inadequate intake of calcium during the bone growth years of adolescence and thus never achieve ideal peak bone mass.</p></div><span id="v906768" class="anchor"></span><div class="para"> <p>The major mechanism of bone loss is increased bone resorption, resulting in decreased bone mass and microarchitectural deterioration, but sometimes bone formation is impaired. The mechanisms of bone loss may involve the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v906771" class="anchor"></span><div class="para"> <p>Local changes in cytokine production, particularly involving cytokines such as receptor activator of nuclear factor kappa-B ligand [RANKL] that increase bone resorption by promoting differentiation and maturation of osteoclasts</p></div></li><li class="topic__listitem"><span id="v906773" class="anchor"></span><div class="para"> <p>Impaired formation response during bone remodeling, probably caused by age-related decline in the number and activity of osteoblasts, partly related to cytokine-mediated increases in the protein sclerostin</p></div></li><li class="topic__listitem"><span id="v906775" class="anchor"></span><div class="para"> <p>Other factors that affect bone resorption such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>parathyroid hormone</span> (PTH) and <span class="genericDrug" data-showrollover="false">vitamin D</span></p></div></li></ul></div><span id="v7821318" class="anchor"></span><div class="para"> <p><b>Idiopathic osteoporosis</b> refers to the rare cases of fragility fractures in children, adolescents, premenopausal women, or men < 50 years with normal gonadal function and no detectable secondary cause, including those with low bone mass for age (low Z-scores on <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013134" data-toggle="tooltip" title="Dual-energy x-ray absorptiometry (DXA)" data-id="d7ad9c3c-127e-4f62-a910-aa15a2eecc93" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">dual-energy x-ray absorptiometry</a><span id="d7ad9c3c-127e-4f62-a910-aa15a2eecc93" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013134"> <span class="tooltip-content"> <span class="tooltip-heading"> Dual-energy x-ray absorptiometry (DXA) </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Dual-energy x-ray absorptiometry (DXA)" loading="lazy"> </span> </a> </span> </span> [DXA] scans). </p></div> </div> </section> </div> </section> <section id="v906778" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v906779" class="anchor"></span> Secondary osteoporosis </h2> <div class="topic__content"> <span id="v906781" class="anchor"></span><div class="para"> <p>Secondary osteoporosis accounts for <span class='symbol'>&lt</span> 5% of osteoporosis in women and about 20% in men. The causes (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"c06e6d61-f310-402b-b4cc-1effc8f3663d","Title":"Causes%20of%20Secondary%20Osteoporosis","ShareUrlTitle":"causes-of-secondary-osteoporosis","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v906785","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ECauses%20of%20Secondary%20Osteoporosis%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>) may also further accelerate bone loss and increase fracture risk in patients with primary osteoporosis. </p></div><span id="v7821320" class="anchor"></span><div class="para"> <p>Patients with <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="0fe28852-232c-4995-94b3-1218b0e891ae" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">chronic kidney disease</a><span id="0fe28852-232c-4995-94b3-1218b0e891ae" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span> may have several reasons for low bone mass, including <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538" data-toggle="tooltip" title="Secondary hyperparathyroidism" data-id="5ffa5e94-5d39-4f61-9a54-8fdc80565de6" data-itemid="e9243843-2c44-45bf-b956-8f604f0e34cb">secondary hyperparathyroidism</a><span id="5ffa5e94-5d39-4f61-9a54-8fdc80565de6" class="d-none xref"> <span class="tooltip-container"> <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538"> <span class="tooltip-content"> <span class="tooltip-heading"> Secondary hyperparathyroidism </span> Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, elevated serum phosphorus, <span class="genericDrug" data-showrollover="false">calcitriol </span>deficiency, abnormalities of serum calcium and <span class="genericDrug" data-showrollover="false">vitamin D</span>, osteomalacia, and low-turnover bone disorders (adynamic bone disease). </p></div> <span id="v906783"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v906787"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"c06e6d61-f310-402b-b4cc-1effc8f3663d","Title":"Causes%20of%20Secondary%20Osteoporosis","ShareUrlTitle":"causes-of-secondary-osteoporosis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v906785","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Causes%20of%20Secondary%20Osteoporosis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="c06e6d61-f310-402b-b4cc-1effc8f3663d"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'c06e6d61-f310-402b-b4cc-1effc8f3663d' }, async: true, success: function (data) { $('#c06e6d61-f310-402b-b4cc-1effc8f3663d').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v906825" class="topic__section FHead"> <h2 id="RiskFactors_v906826" class="topic__header--section" data-originaltitle="Risk Factors"> <span id="v906826" class="anchor"></span> Risk Factors for Osteoporosis </h2> <div class="topic__content"> <span id="v906827" class="anchor"></span><div class="para"> <p>Because mechanical stress, including weight bearing, is necessary for bone growth, immobilization or extended sedentary periods result in bone loss. A low body mass index predisposes to decreased bone mass. </p></div><span id="v71483341" class="anchor"></span><div class="para"> <p>Insufficient dietary intake of calcium, phosphorus, magnesium, and <span class="genericDrug" data-showrollover="false">vitamin D</span> predisposes to bone loss, as does endogenous acidosis. Tobacco and alcohol use also adversely affect bone mass. A family history of osteoporosis, particularly a parental history of hip fracture, also increases risk. Patients who have had one fragility fracture are at increased risk of having other clinical (symptomatic) fractures and clinically asymptomatic vertebral compression fractures.</p></div><span id="v71483342" class="anchor"></span><div class="para"> <p>Certain populations, including White and Asian people, have been thought to have a higher risk of osteoporosis than other groups. However, these purported population differences are coming into question because of newly understood difficulties in sorting individuals into population groups.</p></div> </div> </section> <section id="v906828" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v906829" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v906829" class="anchor"></span> Symptoms and Signs of Osteoporosis </h2> <div class="topic__content"> <span id="v906830" class="anchor"></span><div class="para"> <p>Patients with osteoporosis are asymptomatic unless a fracture has occurred. Nonvertebral fractures are typically symptomatic, but about two thirds of vertebral compression fractures are asymptomatic (although patients may have underlying chronic back pain due to other causes such as osteoarthritis). A vertebral compression fracture that is symptomatic begins with acute onset of pain that usually does not radiate, is aggravated by weight bearing, may be accompanied by point spinal tenderness, and typically begins to subside in 1 week. Residual pain may last for months or be constant, in which case additional fractures or underlying spine disorders (including malignancy or infection) should be suspected.</p></div><span id="v906833" class="anchor"></span><div class="para"> <p>Multiple thoracic compression fractures eventually cause dorsal kyphosis, with exaggerated cervical lordosis (dowager hump). Abnormal stress on the spinal muscles and ligaments may cause chronic, dull, aching pain, particularly in the lower back. Patients may have shortness of breath due to the reduced intrathoracic volume and/or early satiety due to the compression of the abdominal cavity as the rib cage approaches the pelvis. </p></div> </div> </section> <section id="v906836" class="topic__section FHead"> <h2 id="Diagnosis_v906837" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v906837" class="anchor"></span> Diagnosis of Osteoporosis </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v906841" class="anchor"></span><div class="para"> <p>Dual-energy x-ray absorptiometry (DXA)</p></div></li><li class="topic__listitem"><span id="v33013132" class="anchor"></span><div class="para"> <p>X-rays (generally done, but not diagnostic)</p></div></li></ul></div><span id="v71483343" class="anchor"></span><div class="para"> <p>Although low bone mineral density (and the associated increased risk of fracture) can be suggested by x-rays, it should be confirmed by a bone mineral density measurement. Typically DXA is used; quantitative CT scanning can produce similar bone mineral density measurements but is not widely available. </p></div> <section id="v33013133" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v906837_v33013134" class="topic__header--subsection"> <span id="v33013134" class="anchor"></span> Dual-energy x-ray absorptiometry (DXA) </h3> <div class="topic__content"> <span id="v33013135" class="anchor"></span><div class="para"> <p>Bone mineral density should be measured using DXA scan to screen people at risk, provide a quantitative measure of bone loss, help predict the risk of fracture, and monitor those undergoing treatment (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="38380c48-be16-4bf3-bd27-e027f3b3a82d" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">1</a><span id="38380c48-be16-4bf3-bd27-e027f3b3a82d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). In a DXA scan, the target areas, typically the spine and one or both hips, are imaged using x-rays of high and low energy (hence the term "dual energy"). The difference in attenuation between high and low energy beams is a reflection of bone mineral content. The bone mineral content divided by area of bone (also measured in the DXA scan) is the bone mineral density in g/cm<sup>2</sup>. </p></div><span id="v33013151" class="anchor"></span><div class="para"> <p>If the spine or a hip is not available for scanning (eg, because of hardware from prior total hip arthroplasty), the distal radius can be scanned (called "1/3 radius" on the DXA scan report). The distal radius should also be scanned in a patient with hyperparathyroidism because this is the most common site of bone loss in hyperparathyroidism.</p></div><span id="v71483345" class="anchor"></span><div class="para"> <p>DXA results are reported as T-scores and Z-scores. </p></div><span id="v33013152" class="anchor"></span><div class="para"> <p><b>The T-score</b> corresponds to the number of standard deviations that the patient's bone mineral density differs from the peak bone mass of a healthy, young person of the same sex and race/ethnicity. The World Health Organization establishes cutoff values for T-scores that define osteopenia and osteoporosis (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="034da950-f7c4-4a56-9254-5712734da456" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">2</a><span id="034da950-f7c4-4a56-9254-5712734da456" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). A T-score < -1.0 and > -2.5 defines osteopenia. A T-score ≤ -2.5 defines osteoporosis.</p></div><span id="v33013153" class="anchor"></span><div class="para"> <p><b>The Z-score</b> corresponds to the number of standard deviations that the patient's bone mineral density differs from that of a person of the same age and sex and should be used for children, premenopausal women, or men < 50 years. If the Z-score is ≤ -2.0, bone mineral density is low for the patient's age and secondary causes of bone loss should be considered.</p></div> <div class="inlinemedia-component " data-ko-rebind="v34402304" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"DXA Scan","Credits":"\u003cspan id=\u0022v85655412\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Marcy B. Bolster, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"2e0df931-6a4c-4c63-a78d-cdb2bd2ae071","Title":"DXA Scan","ShareUrlTitle":"dxa-scan","Description":"\u003cul\u003e\u003cspan id=\u0022v88864839\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis image is an example of a DXA scan report. In the graph, the area in light blue represents osteopenia and the area in dark blue represents osteoporosis. The patient’s values are represented by the “+” sign inside the circle in each graph.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34402304","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"474","IframeSrc":null,"Target":null}'> </div><span id="v33013137" class="anchor"></span><div class="para"> <p>A <b>DXA scan is recommended</b> for the following patients:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v33013140" class="anchor"></span><div class="para"> <p>All women ≥ 65 years</p></div></li><li class="topic__listitem"><span id="v33013142" class="anchor"></span><div class="para"> <p>Women between menopause and age 65 who have risk factors, including a family history of osteoporosis, a low body mass index, and use of tobacco and/or medications with a high risk of bone loss (eg, corticosteroids, aromatase inhibitors)</p></div></li><li class="topic__listitem"><span id="v33013144" class="anchor"></span><div class="para"> <p>Patients (men and women) of any age who have had fragility fractures</p></div></li><li class="topic__listitem"><span id="v33013146" class="anchor"></span><div class="para"> <p>Patients with evidence on imaging studies of decreased bone mineral density or asymptomatic vertebral compression fractures incidentally noted on imaging studies</p></div></li><li class="topic__listitem"><span id="v33013148" class="anchor"></span><div class="para"> <p>Patients at risk of secondary osteoporosis</p></div></li></ul></div><span id="v33013154" class="anchor"></span><div class="para"> <p>Current central DXA systems can also assess vertebral deformities in the lower thoracic and lumbar spine, a procedure termed vertebral fracture assessment (VFA). Vertebral compression deformities in the absence of trauma, even those clinically silent, are diagnostic of osteoporosis and are predictive of an increased risk of future fractures. VFA is more likely to be useful in patients with height loss ≥ 3 cm. If the VFA results reveal suspected abnormalities, x-rays should be done to confirm the diagnosis.</p></div><span id="v33013155" class="anchor"></span><div class="para"> <p>The need for <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906907" data-toggle="tooltip" title="Antiresorptive medications" data-id="901d2cf7-5bc9-42e9-84cc-567703198d9d" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">pharmacologic therapy</a><span id="901d2cf7-5bc9-42e9-84cc-567703198d9d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906907"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiresorptive medications </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Antiresorptive medications" loading="lazy"> </span> </a> </span> </span> is based on the probability of fracture, which is related to DXA results as well as other factors. The <b>fracture risk assessment (FRAX) score</b> (see <a rel="nofollow" target="_blank" href="https://www.sheffield.ac.uk/FRAX/tool.jsp">Fracture Risk Assessment Tool</a>) predicts the 10-year probability of a major osteoporotic (hip, spine, forearm, or humerus) fracture in untreated patients. The score accounts for several significant risk factors for bone loss and fracture, including bone mineral density, multiple clinical features, and country of origin of the patient (to account for observed population differences). If the FRAX score is above certain thresholds (in the United States, a ≥ 20% probability of major osteoporotic fracture or 3% probability of hip fracture), pharmacologic therapy should generally be recommended (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="b1ddab55-91a6-4f51-b32a-8903d46eaf51" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">3</a><span id="b1ddab55-91a6-4f51-b32a-8903d46eaf51" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). There are limitations to the use of the FRAX score because it does not account for several factors, including history of falls or increased fall risk, the patient's bone mineral density at the lumbar spine, or family history of vertebral fractures.</p></div> </div> </section> <section id="v906843" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v906837_v906844" class="topic__header--subsection"> <span id="v906844" class="anchor"></span> X-rays </h3> <div class="topic__content"> <span id="v906845" class="anchor"></span><div class="para"> <p>Bones show decreased radiodensity and loss of trabecular structure but are inadequate for diagnostic purposes. However, x-rays are important for documenting fractures resulting from bone loss. Loss of vertebral body height and increased biconcavity characterize vertebral compression fractures. Thoracic vertebral fractures may cause anterior wedging of the bone. Vertebral fractures most commonly occur at the mid-thoracic level when due to osteoporosis (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="e4110229-797c-450a-bb47-2b4b6f17ff38" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">4</a><span id="e4110229-797c-450a-bb47-2b4b6f17ff38" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). Vertebral fractures above the mid-thoracic region should raise consideration for malignancy or trauma as the etiology. X-rays of the spine to look for asymptomatic vertebral fragility fractures should be considered in older patients with severe back pain and localized vertebral spinous tenderness and in patients who report > 3 cm height loss. In long bones, although the cortices may be thin, the periosteal surface remains smooth. </p></div> <div class="inlinemedia-component " data-ko-rebind="v25232688" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Osteoporotic Compression Fracture","Credits":"\u003cspan id=\u0022v85660083\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003ePhoto courtesy of Marcy B. Bolster, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"6c0cd8bb-fde8-4bf4-b0ad-3237d39b72f0","Title":"Osteoporotic Compression Fracture","ShareUrlTitle":"osteoporotic-compression-fracture","Description":"\u003cul\u003e\u003cspan id=\u0022v88864841\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis x-ray shows a severe osteoporotic compression fracture of the first lumbar vertebra (L1; arrow).\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/b/o/l/bolster-l1-vert-compression-osteoporosis-pv-red-arrow.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/o/l/bolster-l1-vert-compression-osteoporosis-pv-red-arrow.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v25232688","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"835","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div><span id="v906846" class="anchor"></span><div class="para"> <p>Corticosteroid-related osteoporosis, called glucocorticoid-induced osteoporosis (GIOP), is most likely to cause vertebral compression fractures but may also cause fractures at other sites where osteoporotic fractures are common (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="c300f031-863c-435b-9e99-26294bfd9952" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">5</a><span id="c300f031-863c-435b-9e99-26294bfd9952" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). Hyperparathyroidism can be differentiated when it causes subperiosteal resorption or cystic bone lesions (rarely). Osteomalacia may cause abnormalities on imaging tests similar to those of osteoporosis. </p></div> <a id="v7821331"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--sidebar illustrativeMaterialSidebarTable "> <div class="inlinebox__wrapper" id="v7821336"> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"62a867c1-f2e8-4b71-acc0-529ca9d064cb","Title":"Differentiating%20Osteoporosis%20and%20Osteomalacia","ShareUrlTitle":"differentiating-osteoporosis-and-osteomalacia","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Sidebar","UniqueId":"v7821335","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Differentiating%20Osteoporosis%20and%20Osteomalacia","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Sidebar","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__content--print"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v7821336"></span> <div class="SidebarHalfPage" id="v7821335"> <h3 class="title">Differentiating Osteoporosis and Osteomalacia</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v7821342" class="anchor"></span><div class="para"> <p>Two metabolic bone diseases decrease bone mass: osteoporosis and osteomalacia. </p></div><span id="v7821343" class="anchor"></span><div class="para"> <p>In <b>osteoporosis,</b> bone mass decreases, but the ratio of bone mineral to bone matrix is normal. </p></div><span id="v7821344" class="anchor"></span><div class="para"> <p>In <b>osteomalacia,</b> the ratio of bone mineral to bone matrix is low.</p></div><span id="v7821345" class="anchor"></span><div class="para"> <p>Osteoporosis results from a combination of low peak bone mass, increased bone resorption, and impaired bone formation. Osteomalacia is due to impaired mineralization, usually because of severe <span class="genericDrug" data-showrollover="false">vitamin D</span> deficiency or abnormal <span class="genericDrug" data-showrollover="false">vitamin D</span> metabolism (see <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html" data-toggle="tooltip" title="Vitamin D Deficiency and Dependency" data-id="806cd428-c1c8-4577-b1de-6be07f3c1e6b" data-itemid="592490cc-f7ff-4124-ba17-4a6846cb573b"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Vitamin D</span></a><span id="806cd428-c1c8-4577-b1de-6be07f3c1e6b" class="d-none xref"> <span class="tooltip-container"> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vitamin D Deficiency and Dependency </span> Inadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone mineralization, causing rickets in children and osteomalacia in adults and possibly contributing... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Osteomalacia can be caused by disorders that interfere with <span class="genericDrug" data-showrollover="false">vitamin D</span> absorption (eg, <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html" data-toggle="tooltip" title="Celiac Disease" data-id="a5f9354e-25eb-44fd-a51d-90149730da4a" data-itemid="a7a2c32f-a446-4520-9a65-cd8e39c340a3">celiac disease</a><span id="a5f9354e-25eb-44fd-a51d-90149730da4a" class="d-none xref"> <span class="tooltip-container"> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Celiac Disease </span> Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/9/499-dermatitis-herpetiformis-slide-10-spriinger-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Celiac Disease" loading="lazy"> </span> </a> </span> </span>) and by certain drugs (eg, <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html" data-toggle="tooltip" title="Antiseizure Medications" data-id="0d431b96-e6f6-406b-9e04-ad8c11391fc9" data-itemid="97357749-f77d-48ea-89ca-8ce1c5313333">antiseizure drugs</a><span id="0d431b96-e6f6-406b-9e04-ad8c11391fc9" class="d-none xref"> <span class="tooltip-container"> <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiseizure Medications </span> No single medication controls all types of seizures, and different patients require different medications. Some patients require multiple medications. (See also the practice guideline for the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Osteoporosis is much more common than osteomalacia in the United States. The two disorders may coexist, and their clinical expression is similar; moreover, patients with osteoporosis may have mild to moderate <span class="genericDrug" data-showrollover="false">vitamin D</span> deficiency.</p></div><span id="v7821347" class="anchor"></span><div class="para"> <p>Osteomalacia should be suspected if the patient has bone pain, recurrent rib or other unusual fractures, and the <span class="genericDrug" data-showrollover="false">vitamin D</span> level is consistently very low. To definitively differentiate between the two disorders, clinicians can do a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span>-labeled bone biopsy, but this is rarely warranted.</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> </div> <!-- Type: Sidebar --> </div> </div> </section> <section id="v906876" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v906837_v906877" class="topic__header--subsection"> <span id="v906877" class="anchor"></span> Other testing </h3> <div class="topic__content"> <span id="v906879" class="anchor"></span><div class="para"> <p>An evaluation for secondary causes of bone loss should be considered in a patient with a Z-score ≤ -2.0. Laboratory testing should usually include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v7821359" class="anchor"></span><div class="para"> <p>Serum calcium, magnesium, and phosphorus </p></div></li><li class="topic__listitem"><span id="v7821361" class="anchor"></span><div class="para"> <p>25-Hydroxy <span class="genericDrug" data-showrollover="false">vitamin D</span> level </p></div></li><li class="topic__listitem"><span id="v7821363" class="anchor"></span><div class="para"> <p>Liver tests, including testing for a low alkaline phosphatase (hypophosphatasia)</p></div></li><li class="topic__listitem"><span id="v7821365" class="anchor"></span><div class="para"> <p>Intact PTH level (<a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v8376320" data-toggle="tooltip" title="Hyperparathyroidism" data-id="86b95f83-3961-4b54-be2c-3da8e4ea0b8f" data-itemid="e9243843-2c44-45bf-b956-8f604f0e34cb">hyperparathyroidism</a><span id="86b95f83-3961-4b54-be2c-3da8e4ea0b8f" class="d-none xref"> <span class="tooltip-container"> <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v8376320"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperparathyroidism </span> Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v7821367" class="anchor"></span><div class="para"> <p>Serum <span class="genericDrug" data-showrollover="false">testosterone</span> in men (<a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html#v1050855" data-toggle="tooltip" title="Diagnosis" data-id="c2fef3c6-882f-413c-9bbe-4db93d4fa5d2" data-itemid="08c92c5b-1f0a-4515-baac-2111cc9d440a">hypogonadism</a><span id="c2fef3c6-882f-413c-9bbe-4db93d4fa5d2" class="d-none xref"> <span class="tooltip-container"> <a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html#v1050855"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Hypogonadism is defined as testosterone deficiency with associated symptoms or signs, deficiency of spermatozoa production, or both. It may result from a disorder of the testes (primary hypogonadism)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v7821370" class="anchor"></span><div class="para"> <p>24-hour urine for calcium and creatinine (hypercalciuria)</p></div></li></ul></div><span id="v7821371" class="anchor"></span><div class="para"> <p>Other tests such as thyroid-stimulating hormone or free thyroxine to check for <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html#v981727" data-toggle="tooltip" title="Diagnosis" data-id="8aac4f7c-ee2e-435c-bd26-c6fd92c97b10" data-itemid="b52c4b2c-cb84-4f5f-914f-572de4874494">hyperthyroidism</a><span id="8aac4f7c-ee2e-435c-bd26-c6fd92c97b10" class="d-none xref"> <span class="tooltip-container"> <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html#v981727"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Hyperthyroidism is characterized by hypermetabolism and elevated serum levels of free thyroid hormones. Symptoms include palpitations, fatigue, weight loss, heat intolerance, anxiety, and tremor... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/7/1/g/71_graves_disease_slide_12_alternative_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis" loading="lazy"> </span> </a> </span> </span>, measurements of urinary free <span class="genericDrug" data-showrollover="false">cortisol</span>, and blood counts and other tests to rule out cancer, especially <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html#v976292" data-toggle="tooltip" title="Diagnosis" data-id="0b8cf855-b0c4-4a01-88a3-3fff83024303" data-itemid="2122755c-8771-4044-bbda-ce815d775832">myeloma</a><span id="0b8cf855-b0c4-4a01-88a3-3fff83024303" class="d-none xref"> <span class="tooltip-container"> <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html#v976292"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Common manifestations include lytic lesions in bones that cause... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis" loading="lazy"> </span> </a> </span> </span> (eg, serum protein electrophoresis, serum free light chains, urine protein electrophoresis), should be considered depending on the clinical presentation.</p></div><span id="v906881" class="anchor"></span><div class="para"> <p>Patients with weight loss should be screened for gastrointestinal disorders (eg, <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html#v893755" data-toggle="tooltip" title="Diagnosis" data-id="3b70887e-8a57-4d31-a6d9-5e567c80cdda" data-itemid="1aa9bcdf-0b1a-46cb-b140-76e99848d0d0">malabsorption</a><span id="3b70887e-8a57-4d31-a6d9-5e567c80cdda" class="d-none xref"> <span class="tooltip-container"> <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html#v893755"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Malabsorption is inadequate assimilation of dietary substances due to defects in digestion, absorption, or transport. Malabsorption can affect macronutrients (eg, proteins, carbohydrates, fats)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html#v894022" data-toggle="tooltip" title="Diagnosis" data-id="50fcf1f1-9fc8-40cc-a8fe-9e475a2bec83" data-itemid="a7a2c32f-a446-4520-9a65-cd8e39c340a3">celiac disease</a><span id="50fcf1f1-9fc8-40cc-a8fe-9e475a2bec83" class="d-none xref"> <span class="tooltip-container"> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html#v894022"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/9/499-dermatitis-herpetiformis-slide-10-spriinger-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis" loading="lazy"> </span> </a> </span> </span>, <a href="./{6FE6E5AA-0E7B-44DC-8AF8-8CBF7D9AB5A8}.html" data-toggle="tooltip" title="Overview of Inflammatory Bowel Disease" data-id="7934cf31-e779-4419-acde-10e04b0fc0fc" data-itemid="6fe6e5aa-0e7b-44dc-8af8-8cbf7d9ab5a8">inflammatory bowel disease</a><span id="7934cf31-e779-4419-acde-10e04b0fc0fc" class="d-none xref"> <span class="tooltip-container"> <a href="./{6FE6E5AA-0E7B-44DC-8AF8-8CBF7D9AB5A8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Inflammatory Bowel Disease </span> Inflammatory bowel disease (IBD), which includes Crohn disease and ulcerative colitis, is a relapsing and remitting condition characterized by chronic inflammation at various sites in the gastrointestinal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) as well as cancer. Bone biopsy is reserved for unusual cases (eg, young patients with fragility fractures and no apparent cause, patients with chronic kidney disease who may have other bone disorders, patients with persistently very low <span class="genericDrug" data-showrollover="false">vitamin D</span> levels suspected of having osteomalacia). </p></div><span id="v7821373" class="anchor"></span><div class="para"> <p>Levels of fasting serum C-telopeptide cross-links (CTX) or urine N-telopeptide cross-links (NTX) reflect increased bone resorption. However, the reliability of the assays vary, which complicates their utility for routine clinical care. Studies suggest that elevated levels of CTX and NTX may be helpful in predicting fracture risk in an untreated patient, monitoring response to antiresorptive therapy, and determining the timing of a drug holiday (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169" data-toggle="tooltip" title="Diagnosis references" data-id="fc6bdaf3-8c52-4d99-9bdc-00eed6db8b4f" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">6</a><span id="fc6bdaf3-8c52-4d99-9bdc-00eed6db8b4f" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013169"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>). In patients on antiresorptive therapy, levels should be markedly suppressed. If not, abnormal absorption or poor adherence to treatment regimen should be suspected. </p></div> </div> </section> <section id="v33013168" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v906837_v33013169" class="topic__header--subsection"> <span id="v33013169" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v33013172" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="http://annals.org/aim/article/2534408/change-bone-mineral-density-indicator-treatment-related-antifracture-effect-routine">Leslie WD, Majumdar SR, Morin SN, Lix LM</a>: Change in bone mineral density is an indicator of treatment-related anti-fracture effect in routine clinical practice: A registry-based cohort study. <i>Ann Intern Med</i> 165(7):465–472, 2016. doi: 10.7326/M15-2937</p></div></li><li class="topic__listitem"><span id="v84056379" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/18180210/">Kanis JA, McCloskey EV, Johansson H, et al</a>: A reference standard for the description of osteoporosis. <i>Bone</i> 42(3):467-475, 2008. doi:10.1016/j.bone.2007.11.001</p></div></li><li class="topic__listitem"><span id="v84056382" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988515/">Siris ES, Adler R, Bilezikian J, et al</a>: The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. <i>Osteoporos Int</i> 25(5):1439-1443, 2014. doi:10.1007/s00198-014-2655-z</p></div></li><li class="topic__listitem"><span id="v84056385" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35307360/">Alsoof D, Anderson G, McDonald CL, et al</a>: Diagnosis and management of vertebral compression fracture. <i>Am J Med</i> 135(7):815-821, 2022. doi:10.1016/j.amjmed.2022.02.035</p></div></li><li class="topic__listitem"><span id="v84056388" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/10841167/">Van Staa TP, Leufkens HG, Abenhaim L, et al</a>: Use of oral corticosteroids and risk of fractures. <i>J Bone Miner Res</i> 15(6):993-1000, 2000. doi:10.1359/jbmr.2000.15.6.993</p></div></li><li class="topic__listitem"><span id="v46189674" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822833/">Lorentzon M, Branco J, Brandi ML et al</a>: Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment, and follow-up or treatment of osteoporosis. <i>Adv Ther</i> 36(10): 2811–2824, 2019. doi: 10.1007/s12325-019-01063-9</p></div></li></ul></div> </div> </section> </div> </section> <section id="v906887" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v906888" class="topic__header--section" data-originaltitle="Treatment"> <span id="v906888" class="anchor"></span> Treatment of Osteoporosis </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v906892" class="anchor"></span><div class="para"> <p>Risk factor modification</p></div></li><li class="topic__listitem"><span id="v906894" class="anchor"></span><div class="para"> <p>Calcium and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> supplements</p></div></li><li class="topic__listitem"><span id="v906896" class="anchor"></span><div class="para"> <p>Antiresorptive medications (eg, bisphosphonates, hormone replacement therapy, a selective <span class="genericDrug" data-showrollover="false">estrogen</span> receptor modulator, receptor activator of nuclear factor kappa-B ligand [RANKL] inhibitor [<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>denosumab</span>])</p></div></li><li class="topic__listitem"><span id="v7821376" class="anchor"></span><div class="para"> <p>Anabolic agents (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>parathyroid hormone</span> (PTH) analogues such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abaloparatide</span>)</p></div></li><li class="topic__listitem"><span id="v46189677" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Romosozumab</span>, a monoclonal antibody against sclerostin with both antiresorptive and anabolic effects</p></div></li></ul></div><span id="v906897" class="anchor"></span><div class="para"> <p>The goals of treatment of osteoporosis are to preserve bone mass, prevent fractures, decrease pain, and maintain function.</p></div><span id="v71483350" class="anchor"></span><div class="para"> <p>The rate of bone loss can be slowed with pharmacotherapy, but adequate calcium and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> ingestion and physical activity are critical to maintaining optimal bone mineral density. Modifiable risk factors should also be addressed.</p></div> <section id="v71483351" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v71483352" class="topic__header--subsection"> <span id="v71483352" class="anchor"></span> Risk factor modification </h3> <div class="topic__content"> <span id="v71483353" class="anchor"></span><div class="para"> <p>Risk factor modifications aim to reduce risk of osteoporosis and risk of fractures. Measures include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v71483356" class="anchor"></span><div class="para"> <p>Doing weight-bearing exercise</p></div></li><li class="topic__listitem"><span id="v71483358" class="anchor"></span><div class="para"> <p>Moderating alcohol intake</p></div></li><li class="topic__listitem"><span id="v71483360" class="anchor"></span><div class="para"> <p> <a href="./{559556CB-4832-446E-944B-416328EBE12B}.html" data-toggle="tooltip" title="Smoking Cessation" data-id="c0fcbc4a-e288-4b7f-8c95-613f341e81a2" data-itemid="559556cb-4832-446e-944b-416328ebe12b">Smoking cessation</a><span id="c0fcbc4a-e288-4b7f-8c95-613f341e81a2" class="d-none xref"> <span class="tooltip-container"> <a href="./{559556CB-4832-446E-944B-416328EBE12B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Smoking Cessation </span> Most people who smoke want to quit and have tried doing so with limited success. Effective interventions include cessation counseling and pharmacologic treatment, such as varenicline, bupropion... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v71483363" class="anchor"></span><div class="para"> <p>Fall prevention measures</p></div></li></ul></div><span id="v71483364" class="anchor"></span><div class="para"> <p>Weight-bearing exercise can help increase bone mineral density (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="a7c8f4d4-d8fa-4ea8-b79a-c558c2ac002e" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">1</a><span id="a7c8f4d4-d8fa-4ea8-b79a-c558c2ac002e" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). The optimal amount of weight-bearing exercise is not established, but an average of 30 minutes a day is recommended (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="50a02bde-28c1-4d25-9ae0-08ffb298d997" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">2</a><span id="50a02bde-28c1-4d25-9ae0-08ffb298d997" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). However, excessive exercise without adequate dietary intake in premenopausal women may lead to weight loss and amenorrhea, and subsequent bone loss. If alcohol is consumed, intake should be no more than 1 drink a day for women and 2 drinks a day for men.</p></div><span id="v71483365" class="anchor"></span><div class="para"> <p>Clinicians should routinely ask about recent falls and otherwise <a href="./{4B859296-A689-45D5-B6DE-AA13A53D3291}.html#v1136816" data-toggle="tooltip" title="Evaluation" data-id="7f73997b-f675-450e-a097-1ed8e0cc1ed7" data-itemid="4b859296-a689-45d5-b6de-aa13a53d3291">assess fall risk</a><span id="7f73997b-f675-450e-a097-1ed8e0cc1ed7" class="d-none xref"> <span class="tooltip-container"> <a href="./{4B859296-A689-45D5-B6DE-AA13A53D3291}.html#v1136816"> <span class="tooltip-content"> <span class="tooltip-heading"> Evaluation </span> A fall is defined as an event that occurs when a person inadvertently drops down to the ground or another lower level; sometimes a body part strikes against an object that breaks the fall. Typically... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Many older patients are at risk of falls because of poor coordination and balance, poor vision, muscle weakness, confusion, and use of <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html#v1144523" data-toggle="tooltip" title="Causes of Orthostatic Hypotension" data-id="d4cda1f7-9996-4d75-b45f-c5b87040b36b" data-itemid="e13e2dec-3994-4abb-a0be-891827685991">medications that cause postural hypotension</a><span id="d4cda1f7-9996-4d75-b45f-c5b87040b36b" class="d-none xref"> <span class="tooltip-container"> <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html#v1144523"> <span class="tooltip-content"> <span class="tooltip-heading"> Causes of Orthostatic Hypotension </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Causes of Orthostatic Hypotension" loading="lazy"> </span> </a> </span> </span> or alter the sensorium. Physical therapists can evaluate a patient's gait and fall risk and help create safe individualized programs of core-strengthening exercises to help increase stability and decrease risk of falls. Educating patients about the risks of falls and fractures, instructing how to safely do daily activities, and modifying the home environment for safety also are important for preventing fractures. </p></div> </div> </section> <section id="v71483368" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v71483369" class="topic__header--subsection"> <span id="v71483369" class="anchor"></span> Calcium and vitamin D </h3> <div class="topic__content"> <span id="v71483370" class="anchor"></span><div class="para"> <p>All men and women should consume at least 1000 mg of elemental calcium daily. An intake of 1200 mg a day (including dietary consumption) is recommended for postmenopausal women and older men and for periods of increased requirements, such as pubertal growth, pregnancy, and lactation. Calcium intake should ideally be from dietary sources, with supplements used if dietary intake is insufficient. Calcium supplements are taken most commonly as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>calcium carbonate</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>calcium citrate</span>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Calcium citrate</span> is better absorbed in patients with achlorhydria, but both are well absorbed when taken with meals. Patients taking gastric acid suppressants (eg, proton pump inhibitors, H2 blockers) or those who have had <a href="./{D5D97F61-2C2C-4E8D-AFDB-D5EAE0DE87F5}.html" data-toggle="tooltip" title="Metabolic and Bariatric Surgery" data-id="747c24d1-45b9-47c2-8ccd-668134ffc6af" data-itemid="d5d97f61-2c2c-4e8d-afdb-d5eae0de87f5">gastric bypass surgery</a><span id="747c24d1-45b9-47c2-8ccd-668134ffc6af" class="d-none xref"> <span class="tooltip-container"> <a href="./{D5D97F61-2C2C-4E8D-AFDB-D5EAE0DE87F5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Metabolic and Bariatric Surgery </span> Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> should take <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>calcium citrate</span> to maximize absorption. Calcium should usually be taken in doses of 500 to 600 mg 2 times a day.</p></div><span id="v71483372" class="anchor"></span><div class="para"> <p><b><span class="genericDrug" data-showrollover="false">Vitamin D</span> supplementation</b> with 600 to 800 units a day is recommended. Patients with <span class="genericDrug" data-showrollover="false">vitamin D</span> deficiency may need even higher doses. Supplemental <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> is usually given as cholecalciferol, the natural form of <span class="genericDrug" data-showrollover="false">vitamin D</span>, although ergocalciferol, the synthetic plant-derived form, is also acceptable. The 25-hydroxy <span class="genericDrug" data-showrollover="false">vitamin D</span> level should be ≥ 30 ng/mL.</p></div> </div> </section> <section id="v906898" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v906899" class="topic__header--subsection"> <span id="v906899" class="anchor"></span> Antiresorptive medications </h3> <div class="topic__content"> <span id="v906907" class="anchor"></span><div class="para"> <p><b>Bisphosphonates</b> are first-line therapy. By inhibiting bone resorption, bisphosphonates preserve bone mass and can decrease vertebral and hip fractures by up to 50% (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="58e6d87d-becc-41d2-ad16-19ab57d8ceb0" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">3</a><span id="58e6d87d-becc-41d2-ad16-19ab57d8ceb0" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Bone turnover is reduced after 3 months of bisphosphonate therapy and fracture risk reduction is evident as early as 1 year after beginning therapy. Bisphosphonates can be given orally or IV. Bisphosphonates include the following:</p></div><span id="v23349505" class="anchor"></span><div class="para"> <p>Evidence supports a treatment duration with oral bisphosphonates (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alendronate</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>risedronate</span>) for 5 years or with IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>zoledronic acid</span> for 3 years; however, a longer treatment duration may be warranted in some patients at particularly high fracture risk (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="de299f88-3b53-4ceb-a383-38238c281f76" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">4</a><span id="de299f88-3b53-4ceb-a383-38238c281f76" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v46189681" class="anchor"></span><div class="para"> <p>Oral bisphosphonates must be taken on an empty stomach with a full (8-oz, 250 mL) glass of water. After administration, the patient must remain upright for at least 30 minutes (60 minutes for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ibandronate</span>) and not take anything else by mouth during this time period, because food decreases bioavailability. These medications are safe to use in patients with a creatinine clearance > 35 mL/minute. Oral bisphosphonates can cause esophageal irritation. Esophageal disorders that delay transit time and symptoms of upper gastrointestinal disorders are relative contraindications to oral bisphosphonates. IV bisphosphonates are indicated if a patient is unable to tolerate or is nonadherent with oral bisphosphonates. </p></div><span id="v23349507" class="anchor"></span><div class="para"> <p> <a href="./{FCB91047-53FA-41A2-8E7E-67080F99CF8D}.html" data-toggle="tooltip" title="Medication-Related Osteonecrosis of the Jaw (MRONJ)" data-id="44f9931c-f539-40f4-9040-34504316292a" data-itemid="fcb91047-53fa-41a2-8e7e-67080f99cf8d">Osteonecrosis of the jaw</a><span id="44f9931c-f539-40f4-9040-34504316292a" class="d-none xref"> <span class="tooltip-container"> <a href="./{FCB91047-53FA-41A2-8E7E-67080F99CF8D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Medication-Related Osteonecrosis of the Jaw (MRONJ) </span> Medication-related osteonecrosis of the jaw has no unanimously accepted definition or etiology but is generally held to be an oral lesion involving bare mandibular or maxillary bone present... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and atypical femoral fractures have been rarely reported in patients receiving antiresorptive therapy with bisphosphonates, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>romosozumab</span>, or <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013175" data-toggle="tooltip" title="Antiresorptive medications" data-id="143d3e30-de83-4122-b852-489015c6b406" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>denosumab</span></a><span id="143d3e30-de83-4122-b852-489015c6b406" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v33013175"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiresorptive medications </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Antiresorptive medications" loading="lazy"> </span> </a> </span> </span> (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="247e752c-711c-4eaa-8fb0-1ccd72af1f2d" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">5</a><span id="247e752c-711c-4eaa-8fb0-1ccd72af1f2d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Risk factors include invasive dental procedures, IV bisphosphonate use, and cancer. The benefits of reduction of osteoporosis-related fractures far outweigh this small risk. Although some dentists ask a patient to discontinue a bisphosphonate for several weeks or months before an invasive dental procedure, it is not clear that doing so decreases the risk of osteonecrosis of the jaw. </p></div><span id="v23349510" class="anchor"></span><div class="para"> <p>Long-term bisphosphonate use may increase the risk of atypical femoral fractures (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="b33a21f7-761f-4212-9ff3-28c16d6827fc" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">6</a><span id="b33a21f7-761f-4212-9ff3-28c16d6827fc" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). These fractures occur in the mid-shaft of the femur with minimal or no trauma and may be preceded by weeks or months of thigh pain. The fractures may be bilateral even if symptoms are only unilateral. </p></div><span id="v46189683" class="anchor"></span><div class="para"> <p>To minimize fracture incidence, consideration should be given to stopping bisphosphonates after about</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v23349515" class="anchor"></span><div class="para"> <p>3 to 5 years of use in patients with osteoporosis (by DXA scan) but few or no other <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906826" data-toggle="tooltip" title="Risk Factors" data-id="7c5bf0de-3964-4ebd-af2f-f1395ebbc473" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">risk factors for bone loss</a><span id="7c5bf0de-3964-4ebd-af2f-f1395ebbc473" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906826"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk Factors </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk Factors" loading="lazy"> </span> </a> </span> </span> (3 years for IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>zoledronic acid</span> and 5 years for oral bisphosphonates)</p></div></li><li class="topic__listitem"><span id="v23349517" class="anchor"></span><div class="para"> <p>5 to 10 years of use in patients with osteoporosis (by DXA scan) and fractures or additional significant ongoing risk factors for bone loss and future fractures (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="e6dbc41d-8181-474e-af3a-fa2f00b534fa" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">7</a><span id="e6dbc41d-8181-474e-af3a-fa2f00b534fa" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>, <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="4dc7f6e7-b92d-41f1-bcd9-ccbcdeb0312e" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">8</a><span id="4dc7f6e7-b92d-41f1-bcd9-ccbcdeb0312e" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>) </p></div></li></ul></div><span id="v23349518" class="anchor"></span><div class="para"> <p>Intermittent cessation of bisphosphonate treatment (drug holiday), as well as initiation and duration of therapy, depend on patient risk factors such as age, comorbidities, prior fracture history, DXA scan results, and fall risk. The drug holiday is 1 year or longer. Patients on a bisphosphonate holiday should be closely monitored for a new fracture or accelerated bone loss evident on a DXA scan, especially after being off therapy for 2 years or more. </p></div><span id="v54412035" class="anchor"></span><div class="para"> <p>During therapy with an antiresorptive medication such as a bisphosphonate, bone turnover is suppressed, as evidenced by low serum or urinary levels of (fasting) N-telopeptide cross-links (NTX) or C-telopeptide cross-links (CTX). Thus, measures of bone turnover markers can help determine adherence to therapy, as well as sufficient absorption, which are particularly useful for monitoring in patients taking oral bisphosphonates. These markers may remain low for ≥ 2 years off therapy. In untreated patients, an increase in levels of bone turnover markers, particularly with higher levels, indicates an increased risk of fracture. However, it is not clear whether levels of bone turnover markers should be used as criteria for when to start or end a drug holiday.</p></div><span id="v54412036" class="anchor"></span><div class="para"> <p>The immediate initiation of a bisphosphonate after an osteoporotic fracture has been controversial because of a theoretical concern that these agents may impede bone healing. However, most experts recommend starting a bisphosphonate during the hospitalization for the fracture (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="3a1e8190-4e22-4189-87ff-1bd798a25640" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">9</a><span id="3a1e8190-4e22-4189-87ff-1bd798a25640" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). There is no reason to delay therapy in order to obtain a DXA scan because a hip or vertebral fragility fracture establishes the presence of osteoporosis.</p></div><span id="v33013175" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Denosumab</span></b> is a monoclonal antibody against the receptor activator of nuclear factor kappa-B ligand (RANKL) and reduces bone resorption by inhibiting osteoclast formation (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="4ac3d1f4-6f77-46cb-b987-f2679b10608b" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">10</a><span id="4ac3d1f4-6f77-46cb-b987-f2679b10608b" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class="genericDrug" data-showrollover="false">Denosumab</span> may be helpful in patients not tolerant of or unresponsive to other therapies or in patients with impaired renal function. This medication has been found to have a good safety profile at 10 years of therapy (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="47a5713f-050b-478a-9026-ab716351531a" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">11</a><span id="47a5713f-050b-478a-9026-ab716351531a" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class="genericDrug" data-showrollover="false">Denosumab</span> is contraindicated in patients with hypocalcemia because it can cause calcium shifts that result in profound hypocalcemia and adverse effects such as tetany. <a href="./{FCB91047-53FA-41A2-8E7E-67080F99CF8D}.html" data-toggle="tooltip" title="Medication-Related Osteonecrosis of the Jaw (MRONJ)" data-id="71847536-d5bf-4ccb-88e2-04cb72c36a36" data-itemid="fcb91047-53fa-41a2-8e7e-67080f99cf8d">Osteonecrosis of the jaw</a><span id="71847536-d5bf-4ccb-88e2-04cb72c36a36" class="d-none xref"> <span class="tooltip-container"> <a href="./{FCB91047-53FA-41A2-8E7E-67080F99CF8D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Medication-Related Osteonecrosis of the Jaw (MRONJ) </span> Medication-related osteonecrosis of the jaw has no unanimously accepted definition or etiology but is generally held to be an oral lesion involving bare mandibular or maxillary bone present... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and atypical femoral fractures have been rarely reported in patients taking <span class="genericDrug" data-showrollover="false">denosumab</span>. </p></div><span id="v39824488" class="anchor"></span><div class="para"> <p>Patients taking <span class="genericDrug" data-showrollover="false">denosumab</span> should <b>not</b> undergo a drug holiday because discontinuation may cause a rapid loss in bone mineral density and, importantly, increase the risk of fractures, particularly vertebral fractures, often multiple (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="d4c354ba-7994-4bc3-8a0f-8a51389c8c68" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">12</a><span id="d4c354ba-7994-4bc3-8a0f-8a51389c8c68" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). If and when <span class="genericDrug" data-showrollover="false">denosumab</span> is discontinued, patients should be transitioned to a bisphosphonate such as IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>zoledronic acid</span> for at least a year, longer if there is ongoing risk of fracture (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="c4f880b1-d8fc-43ab-8041-597cffea83eb" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">13</a><span id="c4f880b1-d8fc-43ab-8041-597cffea83eb" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v84056406" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Raloxifene</span></b> is a selective <span class="genericDrug" data-showrollover="false">estrogen</span> receptor modulator (<a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v82372209" data-toggle="tooltip" title="Selective estrogen receptor modulators (SERMs)" data-id="804eb46a-b6af-4a4e-887a-50b0b04c8513" data-itemid="d7cc01e9-54f0-450d-923f-38543aadbd7c">SERM</a><span id="804eb46a-b6af-4a4e-887a-50b0b04c8513" class="d-none xref"> <span class="tooltip-container"> <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v82372209"> <span class="tooltip-content"> <span class="tooltip-heading"> Selective estrogen receptor modulators (SERMs) </span> Menopause is the permanent cessation of menses (amenorrhea) due to loss of ovarian follicular function. Clinical manifestations may include hot flushes, night sweats, sleep disruption, and genitourinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) that may be appropriate for treatment of osteoporosis in women who cannot take bisphosphonates or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>denosumab</span>. It is given orally once daily and reduces vertebral fractures by about 50% but has not been shown to reduce hip fractures (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="654a52d6-b898-4f35-943e-4b72d2cf1096" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">14</a><span id="654a52d6-b898-4f35-943e-4b72d2cf1096" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class="genericDrug" data-showrollover="false">Raloxifene</span> does not stimulate the uterus and antagonizes <span class="genericDrug" data-showrollover="false">estrogen</span> effects in the breast. It reduces the risk of invasive breast cancer. <span class="genericDrug" data-showrollover="false">Raloxifene</span> may increase risk of thromboembolism.</p></div><span id="v84056413" class="anchor"></span><div class="para"> <p><b>Estrogen</b> may preserve bone mineral density and prevent fractures. However, because of the availability of other more effective treatments and the potential harms associated with estrogen treatment, its use is limited to selected cases. The use of <span class="genericDrug" data-showrollover="false">estrogen</span> increases the risk of thromboembolism and endometrial cancer and may increase the risk of breast cancer. The risk of endometrial cancer can be reduced in women with an intact uterus by taking a progestin with <span class="genericDrug" data-showrollover="false">estrogen</span> (see <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v25242237" data-toggle="tooltip" title="Menopausal Hormone Therapy" data-id="34376559-9572-46e6-9795-4236d179d571" data-itemid="d7cc01e9-54f0-450d-923f-38543aadbd7c">Hormone therapy</a><span id="34376559-9572-46e6-9795-4236d179d571" class="d-none xref"> <span class="tooltip-container"> <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v25242237"> <span class="tooltip-content"> <span class="tooltip-heading"> Menopausal Hormone Therapy </span> Menopause is the permanent cessation of menses (amenorrhea) due to loss of ovarian follicular function. Clinical manifestations may include hot flushes, night sweats, sleep disruption, and genitourinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). However, taking a combination of a progestin and <span class="genericDrug" data-showrollover="false">estrogen</span> increases the risk of breast cancer, coronary artery disease, stroke, and biliary disease. Thus, the potential harms of <span class="genericDrug" data-showrollover="false">estrogen</span> treatment for osteoporosis outweigh its potential benefits for most women.</p></div><span id="v84056419" class="anchor"></span><div class="para"> <p><b>Intranasal salmon <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>calcitonin</span></b> should not regularly be used for treating osteoporosis. Salmon <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>calcitonin</span> may provide short-term analgesia after an acute fracture, such as a painful vertebral fracture, due to an endorphin effect (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="5ce44de5-ebd2-4e68-9e5c-888e5b4a65f3" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">15</a><span id="5ce44de5-ebd2-4e68-9e5c-888e5b4a65f3" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). It has not been shown to reduce fractures.</p></div> </div> </section> <section id="v71483381" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v71483382" class="topic__header--subsection"> <span id="v71483382" class="anchor"></span> Anabolic agents </h3> <div class="topic__content"> <span id="v71483383" class="anchor"></span><div class="para"> <p>Anabolic agents include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span> (synthetic PTH [PTH1-34]) (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="1fd0895b-3796-408a-8e00-d9207dacf0c3" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">16</a><span id="1fd0895b-3796-408a-8e00-d9207dacf0c3" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>) and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abaloparatide</span> (a human PTH analog that binds to PTH type 1 receptor) (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="65f8472d-4e14-4fe5-b642-dd67129b8ab4" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">17</a><span id="65f8472d-4e14-4fe5-b642-dd67129b8ab4" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). They are given daily by subcutaneous injection and increase bone mass, stimulate new bone formation, and reduce the risk of fractures. Patients taking an anabolic agent should have a creatinine clearance > 35 mL/minute. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Romosozumab</span>, the monoclonal antibody against sclerostin, has both anabolic and antiresorptive effects.</p></div><span id="v71483385" class="anchor"></span><div class="para"> <p>These three anabolic agents (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abaloparatide</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>romosozumab</span>) are generally indicated for patients who have the following characteristics:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v71483388" class="anchor"></span><div class="para"> <p>Cannot tolerate antiresorptive medications or have contraindications to their use</p></div></li><li class="topic__listitem"><span id="v71483390" class="anchor"></span><div class="para"> <p>Fail to respond (ie, develop new fractures or lose bone mineral density) to antiresorptive medication, as well as calcium, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span>, and exercise</p></div></li><li class="topic__listitem"><span id="v71483392" class="anchor"></span><div class="para"> <p>Possibly have severe osteoporosis (eg, T-score <span class='symbol'>&lt</span> -3.0) or multiple vertebral fragility fractures</p></div></li><li class="topic__listitem"><span id="v71483394" class="anchor"></span><div class="para"> <p>Have glucocorticoid-induced osteoporosis (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span> only)</p></div></li></ul></div><span id="v71483395" class="anchor"></span><div class="para"> <p>Any of these three anabolic agents can be considered for use during a bisphosphonate holiday.</p></div><span id="v71483396" class="anchor"></span><div class="para"> <p>The use of anabolic agents to treat osteoporosis had been limited to 2 years based on a boxed warning because of concern of increased risk of developing <a href="./{21F88581-172D-4322-B576-5D790A779CB7}.html#v910184" data-toggle="tooltip" title="Osteosarcoma (osteogenic sarcoma)" data-id="4d8d0298-6f9d-4e0b-a749-bf5b13e5138b" data-itemid="21f88581-172d-4322-b576-5d790a779cb7">osteosarcoma</a><span id="4d8d0298-6f9d-4e0b-a749-bf5b13e5138b" class="d-none xref"> <span class="tooltip-container"> <a href="./{21F88581-172D-4322-B576-5D790A779CB7}.html#v910184"> <span class="tooltip-content"> <span class="tooltip-heading"> Osteosarcoma (osteogenic sarcoma) </span> Primary malignant bone tumors are much less common than metastatic bone tumors, particularly in adults. Primary malignant bone tumors include multiple myeloma, osteosarcoma, adamantinoma, chondrosarcoma... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Osteosarcoma (osteogenic sarcoma)" loading="lazy"> </span> </a> </span> </span> in initial 2-year clinical trials, but the restriction of 2 years of therapy is no longer required. Consequently, although 2 years of treatment with an anabolic agent remains a reasonable course of therapy, giving a second 2-year course of therapy can now be considered. However, after completion of a treatment course with an anabolic agent, the bone mineral density gains are quickly lost if a patient is not quickly transitioned to an antiresorptive agent such as a <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906907" data-toggle="tooltip" title="Antiresorptive medications" data-id="3927cb7b-82aa-4b02-9d4b-14c8b3db0793" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">bisphosphonate</a><span id="3927cb7b-82aa-4b02-9d4b-14c8b3db0793" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v906907"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiresorptive medications </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Antiresorptive medications" loading="lazy"> </span> </a> </span> </span>. Anabolic agents should be used before antiresorptive agents (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="e0c39ce8-f58e-458d-937f-d83ea36fded4" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">18</a><span id="e0c39ce8-f58e-458d-937f-d83ea36fded4" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Gains in bone mineral density are greater if an anabolic agent is used prior to an antiresorptive agent (ie, considering an "anabolic window"), and bone mineral density gains are attenuated if an anabolic agent is administered following an antiresorptive medication.</p></div><span id="v71483399" class="anchor"></span><div class="para"> <p>Anabolic agents are safe to initiate at any time after a fracture. It is not clear whether early post-fracture use of anabolic agents accelerates bone healing.</p></div> </div> </section> <section id="v71483400" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v71483401" class="topic__header--subsection"> <span id="v71483401" class="anchor"></span> Other medications for osteoporosis </h3> <div class="topic__content"> <span id="v71483402" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Romosozumab</span></b> is a monoclonal antibody against sclerostin (a small protein made by osteocytes that inhibits new bone formation by osteoblasts). It has both antiresorptive and anabolic effects and has been shown to increase bone mineral density in the hip and lumbar spine and reduce fracture risk in postmenopausal women (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="efd4d3e3-40e3-4ed2-820a-5c9cf49de881" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">19</a><span id="efd4d3e3-40e3-4ed2-820a-5c9cf49de881" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class="genericDrug" data-showrollover="false">Romosozumab</span> is indicated for patients with severe osteoporosis, particularly in older people, those who are frail, and those with an increased risk of falling. It should also be considered in patients who fracture despite adequate antiresorptive therapy. It is given via monthly subcutaneous injection for 1 year (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="44b7d42b-e6ec-4954-a2e5-643fccb05baf" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">20</a><span id="44b7d42b-e6ec-4954-a2e5-643fccb05baf" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v84056424" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Romosozumab</span> treatment for 1 year followed by <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alendronate</span> for 1 year is more efficacious than treatment with <span class="genericDrug" data-showrollover="false">alendronate</span> for 2 years (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="a600d588-c429-47b0-89c0-4cce89960ce5" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">21</a><span id="a600d588-c429-47b0-89c0-4cce89960ce5" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>), and <span class="genericDrug" data-showrollover="false">romosozumab</span> for 1 year followed by <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>denosumab</span> for 2 years decreases fracture risk and increases bone mineral density (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="cc17da29-8dd7-44f9-8742-c89669062552" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">21</a><span id="cc17da29-8dd7-44f9-8742-c89669062552" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). As with <span class="genericDrug" data-showrollover="false">denosumab</span>, when <span class="genericDrug" data-showrollover="false">romosozumab</span> is discontinued, antiresorptive therapy should be given to prevent rapid bone loss (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="c87fb37e-9869-4ecf-89ef-3c90326a0df3" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">22</a><span id="c87fb37e-9869-4ecf-89ef-3c90326a0df3" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class="genericDrug" data-showrollover="false">Romosozumab</span> carries a boxed warning due to increased risk for cardiovascular events, including myocardial infarction, stroke, and cardiovascular death. <span class="genericDrug" data-showrollover="false">Romosozumab</span> should not be initiated within 12 months of a patient having had a myocardial infarction or stroke.</p></div> </div> </section> <section id="v71483415" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v71483416" class="topic__header--subsection"> <span id="v71483416" class="anchor"></span> Monitoring response to treatment </h3> <div class="topic__content"> <span id="v71483417" class="anchor"></span><div class="para"> <p>Monitoring for ongoing bone loss or the response to treatment with serial DXA scans should be done using the same DXA machine, and the comparison should use actual bone mineral density (g/cm<sup>2</sup>) rather than T-score. In patients with osteopenia, DXA should be repeated periodically to determine whether there is ongoing bone loss or development of frank osteoporosis requiring treatment. The frequency for follow-up DXA scanning varies from patient to patient, but some reasonable guidelines are as follows: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v71483420" class="anchor"></span><div class="para"> <p>Patients being treated with oral bisphosphonates: Repeat DXA scan usually after 2 to 3 years of therapy. DXA scan may be repeated more frequently if clinically warranted, for example in a patient taking corticosteroids.</p></div></li><li class="topic__listitem"><span id="v71483422" class="anchor"></span><div class="para"> <p>Patients treated with IV bisphosphonates: Repeat DXA scan for monitoring after 3 years of therapy to help determine if treatment has been adequate or a longer therapy course is warranted.</p></div></li><li class="topic__listitem"><span id="v71483424" class="anchor"></span><div class="para"> <p>Patients treated with anabolic therapy: Repeat DXA scan upon completion of therapy (18 to 24 months of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abaloparatide</span>, 1 year of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>romosozumab</span>) to document improvement in bone mineral density with anabolic therapy and to establish a new baseline.</p></div></li></ul></div><span id="v71483425" class="anchor"></span><div class="para"> <p>Results may help identify patients at higher risk of fractures due to a suboptimal response to osteoporosis treatment. Patients who have a significantly lower bone mineral density despite treatment, or those who fracture while on treatment, should be evaluated for secondary causes of bone loss, poor medication absorption (if taking an oral bisphosphonate), and (except for patients treated with IV bisphosphonates or parenteral medications given in the office) medication adherence. </p></div> </div> </section> <section id="v906945" class="topic__section GHead"> <span></span> <h3 id="Treatment_v906888_v906946" class="topic__header--subsection"> <span id="v906946" class="anchor"></span> Treating pain and maintaining function </h3> <div class="topic__content"> <span id="v906948" class="anchor"></span><div class="para"> <p>Acute back pain resulting from a vertebral compression fracture can be treated with short-term orthopedic bracing as needed, analgesics, and, when muscle spasm is prominent, <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129258" data-toggle="tooltip" title="Heat" data-id="0ffb8c04-092e-4560-a15d-f7b44acbe26e" data-itemid="bb73a9b1-71bc-4025-b61c-e5c302904bb7">moist heat</a><span id="0ffb8c04-092e-4560-a15d-f7b44acbe26e" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129258"> <span class="tooltip-content"> <span class="tooltip-heading"> Heat </span> Treatment of pain and inflammation aims to facilitate movement and improve coordination of muscles and joints. Nonpharmacologic treatments include therapeutic exercise, heat, cold, electrical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129289" data-toggle="tooltip" title="Massage" data-id="3aba0f38-dd4e-40ce-83fb-50c2b20a4a54" data-itemid="bb73a9b1-71bc-4025-b61c-e5c302904bb7">massage</a><span id="3aba0f38-dd4e-40ce-83fb-50c2b20a4a54" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129289"> <span class="tooltip-content"> <span class="tooltip-heading"> Massage </span> Treatment of pain and inflammation aims to facilitate movement and improve coordination of muscles and joints. Nonpharmacologic treatments include therapeutic exercise, heat, cold, electrical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Core-strengthening exercises are helpful for patients who have back pain and a prior healed vertebral fracture. Chronic backache may be relieved by exercises to strengthen paravertebral muscles. Avoiding heavy lifting can help. Bed rest should be minimized, and consistent, carefully designed weight-bearing exercise should be encouraged.</p></div><span id="v906950" class="anchor"></span><div class="para"> <p>In some patients, vertebroplasty or kyphoplasty can be used to relieve severe pain due to a new vertebral fragility fracture; however, the evidence for efficacy is inconclusive (<a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="6e1d6bc4-45e2-419d-be8c-3e5e35d71fd7" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">23</a><span id="6e1d6bc4-45e2-419d-be8c-3e5e35d71fd7" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>, <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493" data-toggle="tooltip" title="Treatment references" data-id="777c9978-273f-4fe6-a6f8-026c31a3e831" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">24</a><span id="777c9978-273f-4fe6-a6f8-026c31a3e831" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html#v39824493"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). In vertebroplasty, methyl methacrylate is injected into the vertebral body. In kyphoplasty, the vertebral body is first expanded with a balloon then injected with methyl methacrylate. These procedures may reduce deformity in the injected vertebrae but do not reduce and may even increase the risk of fractures in adjacent vertebrae. Other adverse effects include rib fractures, cement leakage, pulmonary embolism, and myocardial infarction. Further study to determine indications for these procedures is warranted.</p></div> </div> </section> <section id="v39824492" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v906888_v39824493" class="topic__header--subsection"> <span itemprop="name" id="v39824493" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84056438" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/21735380/">Howe TE, Shea B, Dawson LJ, et al</a>: Exercise for preventing and treating osteoporosis in postmenopausal women. <i>Cochrane Database Syst Rev</i> (7):CD000333, 2011. Published 2011 Jul 6. doi:10.1002/14651858.CD000333.pub2</p></div></li><li class="topic__listitem"><span id="v84056441" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304091/">Brooke-Wavell K, Skelton DA, Barker KL, et al</a>: Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis [published online ahead of print, 2022 May 16]. <i>Br J Sports Med</i> 56(15):837-846, 2022. doi:10.1136/bjsports-2021-104634</p></div></li><li class="topic__listitem"><span id="v84056444" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36592455/">Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C</a>: Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians [published correction appears in <i>Ann Intern Med</i> 176(6):884, 2023]. <i>Ann Intern Med</i> 176(2):182-195, 2023. doi:10.7326/M22-0684</p></div></li><li class="topic__listitem"><span id="v39824496" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427916/">Black DM, Reid IR, Boonen S, et al</a>: The effect of 3 versus 6 years of <span class="genericDrug" data-showrollover="false">zoledronic acid</span> treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). <i>J Bone Miner Res</i> 27(2): 243–254, 2012. doi: 10.1002/jbmr.1494</p></div></li><li class="topic__listitem"><span id="v84056447" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/25414052/">Khan AA, Morrison A, Hanley DA, et al</a>: Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. <i>J Bone Miner Res</i> 30(1):3-23, 2015. doi:10.1002/jbmr.2405</p></div></li><li class="topic__listitem"><span id="v84056450" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30169557/">Black DM, Abrahamsen B, Bouxsein ML, et al</a>: Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. <i>Endocr Rev</i> 40(2):333-368, 2019. doi:10.1210/er.2018-00001</p></div></li><li class="topic__listitem"><span id="v84056453" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17190893/">Black DM, Schwartz AV, Ensrud KE, et al</a>. Effects of continuing or stopping <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alendronate</span> after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. <i>JAMA</i> 296(24):2927-2938, 2006. doi:10.1001/jama.296.24.2927</p></div></li><li class="topic__listitem"><span id="v84056456" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427916/">Black DM, Reid IR, Boonen S, et al</a>: The effect of 3 versus 6 years of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>zoledronic acid</span> treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [published correction appears in <i>J Bone Miner Res</i> 27(12):2612, 2012]. <i>J Bone Miner Res</i> 27(2):243-254, 2012. doi:10.1002/jbmr.1494</p></div></li><li class="topic__listitem"><span id="v46189701" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31538675/">Conley RB, Adib G, Adler RA, et al</a>. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. <i>J Bone Miner Res</i> 35(1):36-52, 2020. doi:10.1002/jbmr.3877</p></div></li><li class="topic__listitem"><span id="v84056460" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/19671655/">Cummings SR, San Martin J, McClung MR, et al</a>: <span class="genericDrug" data-showrollover="false">Denosumab</span> for prevention of fractures in postmenopausal women with osteoporosis [published correction appears in <i>N Engl J Med</i> 361(19):1914, 2009]. <i>N Engl J Med</i> 361(8):756-765, 2009. doi:10.1056/NEJMoa0809493</p></div></li><li class="topic__listitem"><span id="v84056464" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28546097/">Bone HG, Wagman RB, Brandi ML, et al</a>: 10 years of <span class="genericDrug" data-showrollover="false">denosumab</span> treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. <i>Lancet Diabetes Endocrinol</i> 5(7):513-523, 2017. doi:10.1016/S2213-8587(17)30138-9</p></div></li><li class="topic__listitem"><span id="v84056468" class="anchor"></span><div class="para"> <p>12. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32716706/">Lyu H, Yoshida K, Zhao SS, et al</a>. Delayed <span class="genericDrug" data-showrollover="false">Denosumab</span> Injections and Fracture Risk Among Patients With Osteoporosis : A Population-Based Cohort Study. <i>Ann Intern Med</i> 173(7):516-526, 2020. doi:10.7326/M20-0882</p></div></li><li class="topic__listitem"><span id="v84056472" class="anchor"></span><div class="para"> <p>13. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33813753/">Sølling AS, Harsløf T, Langdahl B</a>: Treatment with <span class="genericDrug" data-showrollover="false">zoledronate</span> subsequent to <span class="genericDrug" data-showrollover="false">denosumab</span> in osteoporosis: a 2-year randomized study. <i>J Bone Miner Res</i> 36(7):1245-1254, 2021. doi:10.1002/jbmr.4305</p></div></li><li class="topic__listitem"><span id="v84056477" class="anchor"></span><div class="para"> <p>14. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/10517716/">Ettinger B, Black DM, Mitlak BH, et al</a>. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with <span class="genericDrug" data-showrollover="false">raloxifene</span>: results from a 3-year randomized clinical trial. Multiple Outcomes of <span class="genericDrug" data-showrollover="false">Raloxifene</span> Evaluation (MORE) Investigators [published correction appears in <i>JAMA</i> 282(22):2124, 1999]. <i>JAMA</i> 282(7):637-645, 1999. doi:10.1001/jama.282.7.637</p></div></li><li class="topic__listitem"><span id="v84056482" class="anchor"></span><div class="para"> <p>15. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/21660557/">Knopp-Sihota JA, Newburn-Cook CV, Homik J, et al</a>: <span class="genericDrug" data-showrollover="false">Calcitonin</span> for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. <i>Osteoporos Int</i> 23(1):17-38, 2012. doi:10.1007/s00198-011-1676-0</p></div></li><li class="topic__listitem"><span id="v84056486" class="anchor"></span><div class="para"> <p>16. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/11346808/">Neer RM, Arnaud CD, Zanchetta JR, et al</a>: Effect of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>parathyroid hormone</span> (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. <i>N Engl J Med</i> 344(19):1434-1441, 2001. doi:10.1056/NEJM200105103441904</p></div></li><li class="topic__listitem"><span id="v84056489" class="anchor"></span><div class="para"> <p>17. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/27533157/">Miller PD, Hattersley G, Riis BJ, et al</a>: Effect of <span class="genericDrug" data-showrollover="false">abaloparatide</span> vs placebo on new Vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial [published correction appears in <i>JAMA</i>. 2017 Jan 24;317(4):442]. <i>JAMA</i> 316(7):722-733, 2016. doi:10.1001/jama.2016.11136</p></div></li><li class="topic__listitem"><span id="v84056493" class="anchor"></span><div class="para"> <p>18. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076733/">Curtis EM, Reginster JY, Al-Daghri N, et al</a>: Management of patients at very high risk of osteoporotic fractures through sequential treatments. <i>Aging Clin Exp Res</i> 34(4):695-714, 2022. doi:10.1007/s40520-022-02100-4</p></div></li><li class="topic__listitem"><span id="v46189695" class="anchor"></span><div class="para"> <p>19. <a rel="nofollow" target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/27641143">Cosman F, Crittenden DB, Adachi JD, et al</a>: <span class="genericDrug" data-showrollover="false">Romosozumab</span> treatment in postmenopausal women with osteoporosis. <i>N Engl J Med</i> 375(16):1532-1543, 2016. doi: 10.1056/NEJMoa1607948</p></div></li><li class="topic__listitem"><span id="v46189698" class="anchor"></span><div class="para"> <p>20. <a rel="nofollow" target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/28892457">Saag KG, Petersen J, Brandi ML, et al</a>: <span class="genericDrug" data-showrollover="false">Romosozumab</span> or <span class="genericDrug" data-showrollover="false">alendronate</span> for fracture prevention in women with osteoporosis. <i>N Engl J Med</i> 377(15):1417-1427, 2017. doi: 10.1056/NEJMoa1708322</p></div></li><li class="topic__listitem"><span id="v71483430" class="anchor"></span><div class="para"> <p>21. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30508316/">Lewiecki EM, Dinavahi RV, Lazaretti-Castro M, et al</a>: One year of <span class="genericDrug" data-showrollover="false">romosozumab</span> followed by two years of <span class="genericDrug" data-showrollover="false">denosumab</span> maintains fracture risk reductions: Results of the FRAME Extension Study. <i>J Bone Miner Res</i> 34(3):419-428, 2019. doi: 10.1002/jbmr.3622</p></div></li><li class="topic__listitem"><span id="v84056496" class="anchor"></span><div class="para"> <p>22. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29694685/">McClung MR, Brown JP, Diez-Perez A, et al</a>: Effects of 24 Months of Treatment With <span class="genericDrug" data-showrollover="false">Romosozumab</span> Followed by 12 Months of <span class="genericDrug" data-showrollover="false">Denosumab</span> or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study. <i>J Bone Miner Res</i> 33(8):1397-1406, 2018. doi:10.1002/jbmr.3452</p></div></li><li class="topic__listitem"><span id="v84056501" class="anchor"></span><div class="para"> <p>23. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494647/">Buchbinder R, Johnston RV, Rischin KJ, et al</a>: Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. <i>Cochrane Database Syst Rev</i> 4(4):CD006349, 2018. Published 2018 Apr 4. doi:10.1002/14651858.CD006349.pub3</p></div></li><li class="topic__listitem"><span id="v84056504" class="anchor"></span><div class="para"> <p>24. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31375875/">Lou S, Shi X, Zhang X, Lyu H, Li Z, Wang Y</a>: Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials. <i>Osteoporos Int</i> 30(12):2369-2380, 2019. doi:10.1007/s00198-019-05101-8</p></div></li></ul></div> </div> </section> </div> </section> <section id="v906953" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Prevention_v906954" class="topic__header--section" data-originaltitle="Prevention"> <span id="v906954" class="anchor"></span> Prevention of Osteoporosis </h2> <div class="topic__content"> <span id="v906955" class="anchor"></span><div class="para"> <p>The goals of prevention are 2-fold: preserve bone mass and prevent fractures. Preventive measures are indicated for the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v7821394" class="anchor"></span><div class="para"> <p>Postmenopausal women</p></div></li><li class="topic__listitem"><span id="v7821396" class="anchor"></span><div class="para"> <p>Older men</p></div></li><li class="topic__listitem"><span id="v23349554" class="anchor"></span><div class="para"> <p>Patients who have osteopenia </p></div></li><li class="topic__listitem"><span id="v71483435" class="anchor"></span><div class="para"> <p>Patients who already have osteoporosis (to prevent worsening)</p></div></li><li class="topic__listitem"><span id="v7821398" class="anchor"></span><div class="para"> <p>Patients taking high-dose and/or long-term systemic corticosteroids or aromatase inhibitors </p></div></li><li class="topic__listitem"><span id="v7821404" class="anchor"></span><div class="para"> <p>Patients with secondary causes for bone loss</p></div></li></ul></div><span id="v7821405" class="anchor"></span><div class="para"> <p>Preventive measures for all of these patients include appropriate calcium and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> intake, weight-bearing exercise, tobacco avoidance, and limiting alcohol ingestion. Patients should also be counseled on measures to reduce the risk of falls. In addition, pharmacologic therapy is indicated for most patients who have osteopenia if they are at increased risk of fracture, such as those with a high FRAX score, and patients taking corticosteroids or aromatase inhibitors. Educating patients and the community about the importance of bone health remains of utmost importance.</p></div> </div> </section> <section id="v23349555" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v23349556" class="topic__header--section"> <span id="v23349556" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v23349559" class="anchor"></span><div class="para"> <p>Peak bone mass in men and women occurs around age 30; in women, bone loss accelerates after menopause to about 2% a year for about 10 years.</p></div></li><li class="topic__listitem"><span id="v23349561" class="anchor"></span><div class="para"> <p>Nearly all cases of osteoporosis in men and women are primary, without an identifiable cause.</p></div></li><li class="topic__listitem"><span id="v23349563" class="anchor"></span><div class="para"> <p>Suspect osteoporosis in patients who have fractures caused by unexpectedly little force (fragility fractures) of the spine, humerus, distal radius, or hip.</p></div></li><li class="topic__listitem"><span id="v23349565" class="anchor"></span><div class="para"> <p>Use DXA to measure bone mineral density in women ≥ 65 years; women between menopause and age 65 who have risk factors (eg, family history of osteoporosis, a low body mass index, and use of tobacco and/or medications with a high risk of bone loss [eg, chronic corticosteroid use]); men and women of any age who have fragility fractures; evidence on imaging studies of decreased bone mineral density or asymptomatic vertebral compression fractures; and patients at risk of secondary osteoporosis.</p></div></li><li class="topic__listitem"><span id="v23349567" class="anchor"></span><div class="para"> <p>Consider testing patients for causes of secondary bone loss if they have a Z-score ≤ -2.0, a decline in bone mineral density, an unexplained fracture while on treatment for osteoporosis, or a cause of secondary bone loss is clinically suspected.</p></div></li><li class="topic__listitem"><span id="v23349569" class="anchor"></span><div class="para"> <p>For treatment and prevention, ensure adequate intake of calcium and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span>, using supplements when necessary, and modify risk factors to help preserve bone mass (eg, with weight-bearing exercise and by minimizing use of alcohol and tobacco) and reduce fall risk.</p></div></li><li class="topic__listitem"><span id="v23349571" class="anchor"></span><div class="para"> <p>Medications include antiresorptives (eg, bisphosphonates, a receptor activator of nuclear factor kappa-B ligand [RANKL] inhibitor, a selective <span class="genericDrug" data-showrollover="false">estrogen</span> receptor modulator, medications used for hormone replacement therapy) or anabolic agents such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teriparatide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abaloparatide</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>romosozumab</span>.</p></div></li><li class="topic__listitem"><span id="v71483440" class="anchor"></span><div class="para"> <p>Monitor response to treatment with DXA at appropriate intervals depending upon the specific medication regimen used.</p></div></li></ul></div> </div> </section> <section id="v23349573" class="topic__section FHead"> <h2 id="Further_v23349574" class="topic__header--section"> <span id="v23349574" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v54412038" class="anchor"></span><div class="para"> <p>The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v23349577" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.sheffield.ac.uk/FRAX/tool.jsp">Fracture Risk Assessment Tool</a>: Online tool to evaluate fracture risk of patients</p></div></li><li class="topic__listitem"><span id="v54412040" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32427503/">American Association of Clinical Endocrinology (AACE) Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update</a>: Information for healthcare professionals and their patients about the diagnosis, evaluation, and treatment of postmenopausal osteoporosis</p></div></li><li class="topic__listitem"><span id="v84056508" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36592456/">Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, et al</a>: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians [published correction appears in <i>Ann Intern Med</i>. 176(6):882-884, 2023]. <i>Ann Intern Med</i> 176(2):224-238, 2023. doi:10.7326/M22-1034</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="733.0;MM958">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '733.0;MM958',
 title: 'Osteoporosis',
 itemGuid: 'd664f6b2-f617-4e76-82f0-06eb947c1f80'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{FCB91047-53FA-41A2-8E7E-67080F99CF8D}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Medication-Related Osteonecrosis of the Jaw (MRONJ)</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{A744E1A4-219D-45A4-8FD1-952D5928DF0E}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Paget Disease of Bone</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="e64098cf-8815-49b6-8b39-3d162eea521d_mobile" usemap="#e64098cf-8815-49b6-8b39-3d162eea521d_mobile" width="326" height="90">
 <map name="e64098cf-8815-49b6-8b39-3d162eea521d_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="e64098cf-8815-49b6-8b39-3d162eea521d_tablet" usemap="#e64098cf-8815-49b6-8b39-3d162eea521d_tablet" width="326" height="90">
 <map name="e64098cf-8815-49b6-8b39-3d162eea521d_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="e64098cf-8815-49b6-8b39-3d162eea521d_desktop" usemap="#e64098cf-8815-49b6-8b39-3d162eea521d_desktop" width="326" height="90">
 <map name="e64098cf-8815-49b6-8b39-3d162eea521d_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd01
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="D664F6B2F6174E7682F006EB947C1F80">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v906785'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v906787"></span> <div class="TableHalfPage" id="v906785"> <h3 class="title">Causes of Secondary Osteoporosis</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v906791" class="anchor"></span><div class="para"> <p>Cancer (eg, <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html" data-toggle="tooltip" title="Multiple Myeloma" data-id="cf0418da-3cab-41c4-a15e-c5736dec66e0" data-itemid="2122755c-8771-4044-bbda-ce815d775832">multiple myeloma</a><span id="cf0418da-3cab-41c4-a15e-c5736dec66e0" class="d-none xref"> <span class="tooltip-container"> <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple Myeloma </span> Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Common manifestations include lytic lesions in bones that cause... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Multiple Myeloma" loading="lazy"> </span> </a> </span> </span>)</p></div></td></tr><tr class="even"><td><span id="v906794" class="anchor"></span><div class="para"> <p> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html" data-toggle="tooltip" title="Chronic Obstructive Pulmonary Disease (COPD)" data-id="f46dbd96-4d59-41d8-b62f-f7f0a2197da2" data-itemid="abc32073-47d9-40be-ae70-2c663ffc0c96">COPD</a><span id="f46dbd96-4d59-41d8-b62f-f7f0a2197da2" class="d-none xref"> <span class="tooltip-container"> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Obstructive Pulmonary Disease (COPD) </span> Chronic obstructive pulmonary disease (COPD) is airflow limitation caused by an inflammatory response to inhaled toxins, often cigarette smoke. Alpha-1 antitrypsin deficiency and various occupational... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/o/p/copd_chest_xray_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Obstructive Pulmonary Disease (COPD)" loading="lazy"> </span> </a> </span> </span> (chronic obstructive pulmonary disease) due to the disorder and its treatment with corticosteroids, tobacco use, and decreased physical activity</p></div></td></tr><tr class="odd"><td><span id="v906797" class="anchor"></span><div class="para"> <p> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="932f9654-0ec2-46cc-bd83-fffab2e9797a" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">Chronic kidney disease</a><span id="932f9654-0ec2-46cc-bd83-fffab2e9797a" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v906800" class="anchor"></span><div class="para"> <p>Medications (eg, chronic use of corticosteroids, <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html" data-toggle="tooltip" title="Antiseizure Medications" data-id="2519060c-0cfa-48fa-a8e6-10f7ead442b2" data-itemid="97357749-f77d-48ea-89ca-8ce1c5313333">antiseizure medications</a><span id="2519060c-0cfa-48fa-a8e6-10f7ead442b2" class="d-none xref"> <span class="tooltip-container"> <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiseizure Medications </span> No single medication controls all types of seizures, and different patients require different medications. Some patients require multiple medications. (See also the practice guideline for the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>medroxyprogesterone</span>, aromatase inhibitors, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rosiglitazone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pioglitazone</span>, thyroid replacement therapy, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ethanol</span>, tobacco, <a href="./{7F131B56-AD20-4C9A-9E0F-4157BDB7F9F5}.html#v77992965" data-toggle="tooltip" title="Proton Pump Inhibitors" data-id="0d9d49f7-2849-423a-854c-f8bd07dd9b71" data-itemid="7f131b56-ad20-4c9a-9e0f-4157bdb7f9f5">proton pump inhibitors</a><span id="0d9d49f7-2849-423a-854c-f8bd07dd9b71" class="d-none xref"> <span class="tooltip-container"> <a href="./{7F131B56-AD20-4C9A-9E0F-4157BDB7F9F5}.html#v77992965"> <span class="tooltip-content"> <span class="tooltip-heading"> Proton Pump Inhibitors </span> Medications for decreasing acidity are used for peptic ulcer, gastroesophageal reflux disease (GERD), and many forms of gastritis. Some medications are used in regimens for treating Helicobacter... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, H2 blockers) </p></div></td></tr><tr class="odd"><td><span id="v906803" class="anchor"></span><div class="para"> <p>Endocrine disease (eg, glucocorticoid excess, <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538" data-toggle="tooltip" title="Secondary hyperparathyroidism" data-id="d115dd81-7139-4ca9-8614-8eafafbc2511" data-itemid="e9243843-2c44-45bf-b956-8f604f0e34cb">hyperparathyroidism</a><span id="d115dd81-7139-4ca9-8614-8eafafbc2511" class="d-none xref"> <span class="tooltip-container"> <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538"> <span class="tooltip-content"> <span class="tooltip-heading"> Secondary hyperparathyroidism </span> Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html" data-toggle="tooltip" title="Hyperthyroidism" data-id="059f686d-2e4c-4890-b17b-dfb576e04e1c" data-itemid="b52c4b2c-cb84-4f5f-914f-572de4874494">hyperthyroidism</a><span id="059f686d-2e4c-4890-b17b-dfb576e04e1c" class="d-none xref"> <span class="tooltip-container"> <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperthyroidism </span> Hyperthyroidism is characterized by hypermetabolism and elevated serum levels of free thyroid hormones. Symptoms include palpitations, fatigue, weight loss, heat intolerance, anxiety, and tremor... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/7/1/g/71_graves_disease_slide_12_alternative_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hyperthyroidism" loading="lazy"> </span> </a> </span> </span>, <a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html" data-toggle="tooltip" title="Male Hypogonadism" data-id="715c185e-d154-4028-9915-6916c6581ede" data-itemid="08c92c5b-1f0a-4515-baac-2111cc9d440a">hypogonadism</a><span id="715c185e-d154-4028-9915-6916c6581ede" class="d-none xref"> <span class="tooltip-container"> <a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Male Hypogonadism </span> Hypogonadism is defined as testosterone deficiency with associated symptoms or signs, deficiency of spermatozoa production, or both. It may result from a disorder of the testes (primary hypogonadism)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, hyperprolactinemia, <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="9fd7ab2d-6953-43ec-8aa1-a145a82d168c" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes mellitus</a><span id="9fd7ab2d-6953-43ec-8aa1-a145a82d168c" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div></td></tr><tr class="even"><td><span id="v7821324" class="anchor"></span><div class="para"> <p>Hypercalciuria</p></div></td></tr><tr class="odd"><td><span id="v7821327" class="anchor"></span><div class="para"> <p> <a href="./{E0886941-80AB-495C-941B-174DC6EDA546}.html" data-toggle="tooltip" title="Congenital Hypophosphatasia" data-id="d04f1c37-3459-40a2-a445-09f9ad3a868a" data-itemid="e0886941-80ab-495c-941b-174dc6eda546">Hypophosphatasia</a><span id="d04f1c37-3459-40a2-a445-09f9ad3a868a" class="d-none xref"> <span class="tooltip-container"> <a href="./{E0886941-80AB-495C-941B-174DC6EDA546}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Congenital Hypophosphatasia </span> Congenital hypophosphatasia is absence or low levels of serum alkaline phosphatase due to mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Because serum alkaline... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v46189667" class="anchor"></span><div class="para"> <p> <a href="./{C5CE7FC0-313E-4DA4-A93E-B29F3526B04E}.html" data-toggle="tooltip" title="Hypophosphatemia" data-id="e553e388-4285-4139-a0a6-6f7e96e92ec8" data-itemid="c5ce7fc0-313e-4da4-a93e-b29f3526b04e">Hypophosphatemia</a><span id="e553e388-4285-4139-a0a6-6f7e96e92ec8" class="d-none xref"> <span class="tooltip-container"> <a href="./{C5CE7FC0-313E-4DA4-A93E-B29F3526B04E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypophosphatemia </span> Hypophosphatemia is a serum phosphate concentration < 2.5 mg/dL (0.81 mmol/L). Causes include alcohol use disorder, burns, starvation, and diuretic use. Clinical features include muscle weakness... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (chronic)</p></div></td></tr><tr class="odd"><td><span id="v33013128" class="anchor"></span><div class="para"> <p> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html" data-toggle="tooltip" title="Vitamin D Deficiency and Dependency" data-id="bc04a520-ce28-4a0f-b1d7-838d63570a32" data-itemid="592490cc-f7ff-4124-ba17-4a6846cb573b">Hypovitaminosis D</a><span id="bc04a520-ce28-4a0f-b1d7-838d63570a32" class="d-none xref"> <span class="tooltip-container"> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vitamin D Deficiency and Dependency </span> Inadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone mineralization, causing rickets in children and osteomalacia in adults and possibly contributing... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v906809" class="anchor"></span><div class="para"> <p>Immobilization</p></div></td></tr><tr class="odd"><td><span id="v906812" class="anchor"></span><div class="para"> <p>Liver disease</p></div></td></tr><tr class="even"><td><span id="v906815" class="anchor"></span><div class="para"> <p> <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html" data-toggle="tooltip" title="Overview of Malabsorption" data-id="5fdb0949-f47d-4406-8339-9732c3509d74" data-itemid="1aa9bcdf-0b1a-46cb-b140-76e99848d0d0">Malabsorption syndromes</a><span id="5fdb0949-f47d-4406-8339-9732c3509d74" class="d-none xref"> <span class="tooltip-container"> <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Malabsorption </span> Malabsorption is inadequate assimilation of dietary substances due to defects in digestion, absorption, or transport. Malabsorption can affect macronutrients (eg, proteins, carbohydrates, fats)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v906818" class="anchor"></span><div class="para"> <p>Prolonged weightlessness (as occurs in space flight)</p></div></td></tr><tr class="even"><td><span id="v906821" class="anchor"></span><div class="para"> <p> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html" data-toggle="tooltip" title="Rheumatoid Arthritis (RA)" data-id="011aa12f-6ff2-41f6-8af0-6c244f28c8c5" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">Rheumatoid arthritis</a><span id="011aa12f-6ff2-41f6-8af0-6c244f28c8c5" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Rheumatoid Arthritis (RA) </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rheumatoid Arthritis (RA)" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="x000022" class="anchor"></span><div class="para"> <p> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html" data-toggle="tooltip" title="Celiac Disease" data-id="1b00bc1e-b467-44cd-aa02-9b4d0b7146d8" data-itemid="a7a2c32f-a446-4520-9a65-cd8e39c340a3">Celiac disease</a><span id="1b00bc1e-b467-44cd-aa02-9b4d0b7146d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Celiac Disease </span> Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/4/9/9/499-dermatitis-herpetiformis-slide-10-spriinger-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Celiac Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v7821335'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v7821336"></span> <div class="SidebarHalfPage" id="v7821335"> <h3 class="title">Differentiating Osteoporosis and Osteomalacia</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v7821342" class="anchor"></span><div class="para"> <p>Two metabolic bone diseases decrease bone mass: osteoporosis and osteomalacia. </p></div><span id="v7821343" class="anchor"></span><div class="para"> <p>In <b>osteoporosis,</b> bone mass decreases, but the ratio of bone mineral to bone matrix is normal. </p></div><span id="v7821344" class="anchor"></span><div class="para"> <p>In <b>osteomalacia,</b> the ratio of bone mineral to bone matrix is low.</p></div><span id="v7821345" class="anchor"></span><div class="para"> <p>Osteoporosis results from a combination of low peak bone mass, increased bone resorption, and impaired bone formation. Osteomalacia is due to impaired mineralization, usually because of severe <span class="genericDrug" data-showrollover="false">vitamin D</span> deficiency or abnormal <span class="genericDrug" data-showrollover="false">vitamin D</span> metabolism (see <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html" data-toggle="tooltip" title="Vitamin D Deficiency and Dependency" data-id="54a4b772-a3f1-42a9-875c-ca108760c26b" data-itemid="592490cc-f7ff-4124-ba17-4a6846cb573b"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Vitamin D</span></a><span id="54a4b772-a3f1-42a9-875c-ca108760c26b" class="d-none xref"> <span class="tooltip-container"> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vitamin D Deficiency and Dependency </span> Inadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone mineralization, causing rickets in children and osteomalacia in adults and possibly contributing... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Osteomalacia can be caused by disorders that interfere with <span class="genericDrug" data-showrollover="false">vitamin D</span> absorption (eg, <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html" data-toggle="tooltip" title="Celiac Disease" data-id="85a9717f-a360-4962-a893-c085c0df7057" data-itemid="a7a2c32f-a446-4520-9a65-cd8e39c340a3">celiac disease</a><span id="85a9717f-a360-4962-a893-c085c0df7057" class="d-none xref"> <span class="tooltip-container"> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Celiac Disease </span> Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/4/9/9/499-dermatitis-herpetiformis-slide-10-spriinger-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Celiac Disease" loading="lazy"> </span> </a> </span> </span>) and by certain drugs (eg, <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html" data-toggle="tooltip" title="Antiseizure Medications" data-id="05e9885d-5e95-4bc6-9e11-a84d10e360f9" data-itemid="97357749-f77d-48ea-89ca-8ce1c5313333">antiseizure drugs</a><span id="05e9885d-5e95-4bc6-9e11-a84d10e360f9" class="d-none xref"> <span class="tooltip-container"> <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiseizure Medications </span> No single medication controls all types of seizures, and different patients require different medications. Some patients require multiple medications. (See also the practice guideline for the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Osteoporosis is much more common than osteomalacia in the United States. The two disorders may coexist, and their clinical expression is similar; moreover, patients with osteoporosis may have mild to moderate <span class="genericDrug" data-showrollover="false">vitamin D</span> deficiency.</p></div><span id="v7821347" class="anchor"></span><div class="para"> <p>Osteomalacia should be suspected if the patient has bone pain, recurrent rib or other unusual fractures, and the <span class="genericDrug" data-showrollover="false">vitamin D</span> level is consistently very low. To definitively differentiate between the two disorders, clinicians can do a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span>-labeled bone biopsy, but this is rarely warranted.</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v906785'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v906787"></span> <div class="TableHalfPage" id="v906785"> <h3 class="title">Causes of Secondary Osteoporosis</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v906791" class="anchor"></span><div class="para"> <p>Cancer (eg, <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html" data-toggle="tooltip" title="Multiple Myeloma" data-id="cf0418da-3cab-41c4-a15e-c5736dec66e0" data-itemid="2122755c-8771-4044-bbda-ce815d775832">multiple myeloma</a><span id="cf0418da-3cab-41c4-a15e-c5736dec66e0" class="d-none xref"> <span class="tooltip-container"> <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple Myeloma </span> Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Common manifestations include lytic lesions in bones that cause... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Multiple Myeloma" loading="lazy"> </span> </a> </span> </span>)</p></div></td></tr><tr class="even"><td><span id="v906794" class="anchor"></span><div class="para"> <p> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html" data-toggle="tooltip" title="Chronic Obstructive Pulmonary Disease (COPD)" data-id="f46dbd96-4d59-41d8-b62f-f7f0a2197da2" data-itemid="abc32073-47d9-40be-ae70-2c663ffc0c96">COPD</a><span id="f46dbd96-4d59-41d8-b62f-f7f0a2197da2" class="d-none xref"> <span class="tooltip-container"> <a href="./{ABC32073-47D9-40BE-AE70-2C663FFC0C96}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Obstructive Pulmonary Disease (COPD) </span> Chronic obstructive pulmonary disease (COPD) is airflow limitation caused by an inflammatory response to inhaled toxins, often cigarette smoke. Alpha-1 antitrypsin deficiency and various occupational... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/o/p/copd_chest_xray_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Obstructive Pulmonary Disease (COPD)" loading="lazy"> </span> </a> </span> </span> (chronic obstructive pulmonary disease) due to the disorder and its treatment with corticosteroids, tobacco use, and decreased physical activity</p></div></td></tr><tr class="odd"><td><span id="v906797" class="anchor"></span><div class="para"> <p> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="932f9654-0ec2-46cc-bd83-fffab2e9797a" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">Chronic kidney disease</a><span id="932f9654-0ec2-46cc-bd83-fffab2e9797a" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v906800" class="anchor"></span><div class="para"> <p>Medications (eg, chronic use of corticosteroids, <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html" data-toggle="tooltip" title="Antiseizure Medications" data-id="2519060c-0cfa-48fa-a8e6-10f7ead442b2" data-itemid="97357749-f77d-48ea-89ca-8ce1c5313333">antiseizure medications</a><span id="2519060c-0cfa-48fa-a8e6-10f7ead442b2" class="d-none xref"> <span class="tooltip-container"> <a href="./{97357749-F77D-48EA-89CA-8CE1C5313333}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiseizure Medications </span> No single medication controls all types of seizures, and different patients require different medications. Some patients require multiple medications. (See also the practice guideline for the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>medroxyprogesterone</span>, aromatase inhibitors, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rosiglitazone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pioglitazone</span>, thyroid replacement therapy, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ethanol</span>, tobacco, <a href="./{7F131B56-AD20-4C9A-9E0F-4157BDB7F9F5}.html#v77992965" data-toggle="tooltip" title="Proton Pump Inhibitors" data-id="0d9d49f7-2849-423a-854c-f8bd07dd9b71" data-itemid="7f131b56-ad20-4c9a-9e0f-4157bdb7f9f5">proton pump inhibitors</a><span id="0d9d49f7-2849-423a-854c-f8bd07dd9b71" class="d-none xref"> <span class="tooltip-container"> <a href="./{7F131B56-AD20-4C9A-9E0F-4157BDB7F9F5}.html#v77992965"> <span class="tooltip-content"> <span class="tooltip-heading"> Proton Pump Inhibitors </span> Medications for decreasing acidity are used for peptic ulcer, gastroesophageal reflux disease (GERD), and many forms of gastritis. Some medications are used in regimens for treating Helicobacter... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, H2 blockers) </p></div></td></tr><tr class="odd"><td><span id="v906803" class="anchor"></span><div class="para"> <p>Endocrine disease (eg, glucocorticoid excess, <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538" data-toggle="tooltip" title="Secondary hyperparathyroidism" data-id="d115dd81-7139-4ca9-8614-8eafafbc2511" data-itemid="e9243843-2c44-45bf-b956-8f604f0e34cb">hyperparathyroidism</a><span id="d115dd81-7139-4ca9-8614-8eafafbc2511" class="d-none xref"> <span class="tooltip-container"> <a href="./{E9243843-2C44-45BF-B956-8F604F0E34CB}.html#v26434538"> <span class="tooltip-content"> <span class="tooltip-heading"> Secondary hyperparathyroidism </span> Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html" data-toggle="tooltip" title="Hyperthyroidism" data-id="059f686d-2e4c-4890-b17b-dfb576e04e1c" data-itemid="b52c4b2c-cb84-4f5f-914f-572de4874494">hyperthyroidism</a><span id="059f686d-2e4c-4890-b17b-dfb576e04e1c" class="d-none xref"> <span class="tooltip-container"> <a href="./{B52C4B2C-CB84-4F5F-914F-572DE4874494}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperthyroidism </span> Hyperthyroidism is characterized by hypermetabolism and elevated serum levels of free thyroid hormones. Symptoms include palpitations, fatigue, weight loss, heat intolerance, anxiety, and tremor... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/7/1/g/71_graves_disease_slide_12_alternative_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hyperthyroidism" loading="lazy"> </span> </a> </span> </span>, <a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html" data-toggle="tooltip" title="Male Hypogonadism" data-id="715c185e-d154-4028-9915-6916c6581ede" data-itemid="08c92c5b-1f0a-4515-baac-2111cc9d440a">hypogonadism</a><span id="715c185e-d154-4028-9915-6916c6581ede" class="d-none xref"> <span class="tooltip-container"> <a href="./{08C92C5B-1F0A-4515-BAAC-2111CC9D440A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Male Hypogonadism </span> Hypogonadism is defined as testosterone deficiency with associated symptoms or signs, deficiency of spermatozoa production, or both. It may result from a disorder of the testes (primary hypogonadism)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, hyperprolactinemia, <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="9fd7ab2d-6953-43ec-8aa1-a145a82d168c" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">diabetes mellitus</a><span id="9fd7ab2d-6953-43ec-8aa1-a145a82d168c" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div></td></tr><tr class="even"><td><span id="v7821324" class="anchor"></span><div class="para"> <p>Hypercalciuria</p></div></td></tr><tr class="odd"><td><span id="v7821327" class="anchor"></span><div class="para"> <p> <a href="./{E0886941-80AB-495C-941B-174DC6EDA546}.html" data-toggle="tooltip" title="Congenital Hypophosphatasia" data-id="d04f1c37-3459-40a2-a445-09f9ad3a868a" data-itemid="e0886941-80ab-495c-941b-174dc6eda546">Hypophosphatasia</a><span id="d04f1c37-3459-40a2-a445-09f9ad3a868a" class="d-none xref"> <span class="tooltip-container"> <a href="./{E0886941-80AB-495C-941B-174DC6EDA546}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Congenital Hypophosphatasia </span> Congenital hypophosphatasia is absence or low levels of serum alkaline phosphatase due to mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Because serum alkaline... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v46189667" class="anchor"></span><div class="para"> <p> <a href="./{C5CE7FC0-313E-4DA4-A93E-B29F3526B04E}.html" data-toggle="tooltip" title="Hypophosphatemia" data-id="e553e388-4285-4139-a0a6-6f7e96e92ec8" data-itemid="c5ce7fc0-313e-4da4-a93e-b29f3526b04e">Hypophosphatemia</a><span id="e553e388-4285-4139-a0a6-6f7e96e92ec8" class="d-none xref"> <span class="tooltip-container"> <a href="./{C5CE7FC0-313E-4DA4-A93E-B29F3526B04E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypophosphatemia </span> Hypophosphatemia is a serum phosphate concentration < 2.5 mg/dL (0.81 mmol/L). Causes include alcohol use disorder, burns, starvation, and diuretic use. Clinical features include muscle weakness... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (chronic)</p></div></td></tr><tr class="odd"><td><span id="v33013128" class="anchor"></span><div class="para"> <p> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html" data-toggle="tooltip" title="Vitamin D Deficiency and Dependency" data-id="bc04a520-ce28-4a0f-b1d7-838d63570a32" data-itemid="592490cc-f7ff-4124-ba17-4a6846cb573b">Hypovitaminosis D</a><span id="bc04a520-ce28-4a0f-b1d7-838d63570a32" class="d-none xref"> <span class="tooltip-container"> <a href="./{592490CC-F7FF-4124-BA17-4A6846CB573B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Vitamin D Deficiency and Dependency </span> Inadequate exposure to sunlight predisposes to vitamin D deficiency. Deficiency impairs bone mineralization, causing rickets in children and osteomalacia in adults and possibly contributing... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="even"><td><span id="v906809" class="anchor"></span><div class="para"> <p>Immobilization</p></div></td></tr><tr class="odd"><td><span id="v906812" class="anchor"></span><div class="para"> <p>Liver disease</p></div></td></tr><tr class="even"><td><span id="v906815" class="anchor"></span><div class="para"> <p> <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html" data-toggle="tooltip" title="Overview of Malabsorption" data-id="5fdb0949-f47d-4406-8339-9732c3509d74" data-itemid="1aa9bcdf-0b1a-46cb-b140-76e99848d0d0">Malabsorption syndromes</a><span id="5fdb0949-f47d-4406-8339-9732c3509d74" class="d-none xref"> <span class="tooltip-container"> <a href="./{1AA9BCDF-0B1A-46CB-B140-76E99848D0D0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Malabsorption </span> Malabsorption is inadequate assimilation of dietary substances due to defects in digestion, absorption, or transport. Malabsorption can affect macronutrients (eg, proteins, carbohydrates, fats)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="v906818" class="anchor"></span><div class="para"> <p>Prolonged weightlessness (as occurs in space flight)</p></div></td></tr><tr class="even"><td><span id="v906821" class="anchor"></span><div class="para"> <p> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html" data-toggle="tooltip" title="Rheumatoid Arthritis (RA)" data-id="011aa12f-6ff2-41f6-8af0-6c244f28c8c5" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">Rheumatoid arthritis</a><span id="011aa12f-6ff2-41f6-8af0-6c244f28c8c5" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Rheumatoid Arthritis (RA) </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Rheumatoid Arthritis (RA)" loading="lazy"> </span> </a> </span> </span></p></div></td></tr><tr class="odd"><td><span id="x000022" class="anchor"></span><div class="para"> <p> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html" data-toggle="tooltip" title="Celiac Disease" data-id="1b00bc1e-b467-44cd-aa02-9b4d0b7146d8" data-itemid="a7a2c32f-a446-4520-9a65-cd8e39c340a3">Celiac disease</a><span id="1b00bc1e-b467-44cd-aa02-9b4d0b7146d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{A7A2C32F-A446-4520-9A65-CD8E39C340A3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Celiac Disease </span> Celiac disease is an immunologically mediated disease in genetically susceptible people caused by intolerance to gluten, resulting in mucosal inflammation and villous atrophy, which causes malabsorption... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="/-/media/manual/professional/images/4/9/9/499-dermatitis-herpetiformis-slide-10-spriinger-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Celiac Disease" loading="lazy"> </span> </a> </span> </span></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>